Document:

EX-10.1

Exhibit 10.1

SECOND AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

BY AND AMONG

CIFC CORP.

DFR HOLDINGS, LLC

CIFC PARENT HOLDINGS LLC

AND

GE CAPITAL EQUITY INVESTMENTS, INC.

Dated as of September 24, 2012

1

TABLE OF CONTENTS

	 	 	 	 	 
	 

	 
	 	Page
	Section 1. Definitions
	 	 	4	 
	Section 2. Demand Registration and Piggyback Rights on Demand
	 	 	8	 
	Registrations
	 	 	 	 
	Section 3. Piggyback Rights on Company or Third Party Registrations
	 	 	11	 
	Section 4. Registration Procedures
	 	 	13	 
	Section 5. Registration Expenses
	 	 	17	 
	Section 6. Indemnification
	 	 	17	 
	Section 7. Facilitation of Sales Pursuant to Rule 144
	 	 	20	 
	Section 8. Miscellaneous
	 	 	20	 

2

SECOND AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is
made and entered into as of September 24, 2012, by and among CIFC Corp., a Delaware corporation
(the “Company”), DFR Holdings, LLC , a Delaware limited liability company (together with
its successors and assigns, “DFR Holdings”), CIFC Parent Holdings LLC, a Delaware limited
liability company (together with its successors and assigns, “CIFC Parent”), and GE Capital
Equity Investments, Inc., a Delaware corporation (together with its successors and assigns,
“GECEII” and, collectively with DFR Holdings and CIFC Parent, the “Investors”).

WHEREAS, pursuant to that certain Asset Purchase Agreement, dated as of July 30, 2012 (the
“Asset Purchase Agreement”), among the Company, CIFC Asset Management LLC, an affiliate of
the Company (“CIFCAM”), GE Capital Debt Advisors LLC (“GECDA”), and General
Electric Capital Corporation, the Company issued to GECEII 1,000,000 shares (the “GECEII
Shares”) of common stock of the Company, par value $0.001 per share (the “Common
Stock”), and a warrant (the “Warrant”) to purchase up to 2,000,000 shares of Common
Stock or (if exercised by the Initial Holder (as defined in the Warrant)) Preferred Stock (as
defined in the Warrant) (the shares issuable upon the exercise of the Warrant, and any other
securities issued in respect thereof or into which such shares or other securities shall be
converted or exchanged in connection with stock splits, reverse stock splits, stock dividends or
distributions, combinations or any other recapitalizations after the date of the Investment
Agreement (as defined below), the “Warrant Shares”);

WHEREAS, as of the date hereof, DFR Holdings owns (i) 4,545,455 shares of Common Stock (the
“DFR Holdings Shares”) and (ii) Senior Subordinated Convertible Notes in the original
principal amount of twenty-five million dollars ($25,000,000) and due December 9, 2017 (the
“Convertible Notes”), which are convertible into shares of Common Stock (the
“Conversion Shares”);

WHEREAS, as of the date hereof, CIFC Parent owns 9,090,909 shares of Common Stock (the
“CIFC Shares”);

WHEREAS, the Company, DFR Holdings and CIFC Parent are parties to the Amended and Restated
Registration Rights Agreement, dated as of April 13, 2011 (the “A&R Agreement”);

WHEREAS, DFR Holdings and CIFC Parent have established certain terms and conditions concerning
the corporate governance of the Company, the CIFC Shares and the DFR Holdings Shares and related
provisions concerning the relationship of DFR Holdings and CIFC Parent with, and their investments
in, the Company, as provided in the Amended and Restated Stockholders Agreement, dated as of April
13, 2011 and as amended, supplemented or otherwise modified from time to time (the
“Stockholders Agreement”);

WHEREAS, GECEII and the Company are establishing certain terms and conditions concerning the
corporate governance of the Company, the GECEII Shares (as defined below), the Warrant Shares and
related provisions concerning the relationship of GECEII with, and its investment in, the Company,
as provided in the Investment Agreement, dated as of the date hereof (the “Investment
Agreement”);

WHEREAS, the execution and delivery of this Agreement is a condition to the obligations of the
Company, CIFCAM and GECDA to consummate the Transactions (as defined in the Asset Purchase
Agreement); and

WHEREAS, the Company, DFR Holdings and CIFC Parent desire to amend and restate the A&R
Agreement and establish in this Agreement certain terms and conditions concerning the registration
rights with respect to the CIFC Shares, the DFR Holdings Shares, the Conversion Shares, the GECEII
Shares and the Warrant Shares (to the extent exercised for shares of Common Stock or otherwise
converted to shares of Common Stock) and related provisions concerning the relationship of the
Investors with, and their investments in, the Company from and after the Closing (as defined in the
Asset Purchase Agreement).

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged,
the parties hereto agree as follows:

Section 1. Definitions. As used in this Agreement, the following terms shall have the
respective meanings set forth in this Section 1:

“Acquisition Agreement” means the Acquisition and Investment Agreement, dated as of
March 22, 2010, by and among the Company, Bounty Investments, LLC and Columbus Nova Credit
Investment Management, LLC.

“Affiliate” means, with respect to any Person, any other Person, directly or
indirectly through one or more intermediaries, controlling, controlled by or under common control
with such Person. The term “control” (including, with correlative meaning, the terms “controlled
by” and “under common control with”), as applied to any Person, means the possession, directly or
indirectly, of the power to direct or cause the direction of the management and policies of such
Person, whether through the ownership of voting or other securities, by contract or otherwise.

“Automatic Shelf Registration Statement” means an “automatic shelf registration
statement” as defined under Rule 405.

“Business Day” means a day other than Saturday, Sunday or any other day on which banks
located in New York, New York are authorized or obligated Law to close.

“Commission” means the United States Securities and Exchange Commission or any
successor entity thereto.

“Demand Registration” has the meaning set forth in Section 2(a).

“Demanding Holder” means the Holder requesting registration of Registrable Securities
pursuant to

Section 2(a).

“Effective Date” means the time and date that the Registration Statement filed
pursuant to Section 2(a) is first declared effective by the Commission or otherwise becomes
effective.

“Effectiveness Date” means, with respect to each Registration Statement that may be
required pursuant to Section 2(a)) hereof: (i) if the Company is a WKSI at such time, the
date such additional Registration Statement is filed; or (ii) if the Company is not a WKSI at such
time, the earlier of: (x) the forty-fifth (45th) day following the written notice of
demand therefor by the Demanding Holder and (y) the fifth (5th) Trading Day following
the date on which the Company is notified by the Commission that such additional Registration
Statement will not be reviewed or is no longer subject to further review and comments.

“Effectiveness Period” has the meaning set forth in Section 2(a).

“Electing Holder” means (a) with respect to any Demand Registration pursuant to
Section 2(a), each Holder other than the Demanding Holder that requests to include
Registrable Securities in such Demand Registration and (b) with respect to any Piggyback
Registration pursuant to Section 3(a), each Holder that requests to include Registrable
Securities in such Piggyback Registration.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Filing Date” means with respect to each Registration Statement that may be required
pursuant to Section 2(a) hereof, (x) if the Company is then eligible to file a Registration
Statement on Form S-3, the fifteenth (15th) day following the written notice of demand
therefor by the Demanding Holder or (y) if the Company is not then eligible to file a Registration
Statement on Form S-3, the thirtieth (30th) day following the written notice of demand
therefor by the Demanding Holder, provided, however, that if the Filing Date falls
on a Saturday, Sunday or other day that the Commission is closed for business, the Filing Date
shall be extended to the next Business Day on which the Commission is open for business.

“Freely Tradable” means, with respect to any security, a security that (i) is eligible
to be sold by the Holder thereof without any volume or manner of sale restrictions under the
Securities Act pursuant to Rule 144 or (ii) (A) if certificated, does not and is not required to
bear legends restricting the transfer thereof and (B) if not certificated, does not and is not
required to bear a restricted CUSIP number and/or is not and is not required to be held in a
“restricted account” on behalf of a Holder by the Company’s transfer agent.

“GECEII Shares” has the meaning set forth in the recitals hereto.

“Governmental Authority” means any foreign, federal, state or local governmental,
judicial, legislative, regulatory or administrative agency, commission or authority, and any court,
tribunal or arbitrator(s) of competent jurisdiction, including Self-Regulatory Organizations.

“Holder” or “Holders” means the record holder or holders, as the case may be,
from time to time of Convertible Notes, the Warrant and any Registrable Securities.

“Indemnified Party” has the meaning set forth in Section 6(c).

“Indemnifying Party” has the meaning set forth in Section 6(c).

“Investor Shares” means the CIFC Shares, the DFR Holdings Shares, the GECEII Shares
and any other shares of Common Stock held by CIFC Parent, DFR Holdings, GECEII or any other
Investor.

“Law” means any statute, code, Order, law, ordinance, rule, regulation or other
requirement of any Governmental Authority (including, for the sake of clarity, common law).

“Losses” has the meaning set forth in Section 6(a).

“Order” means any judgment, order, injunction, stipulation, decree, writ, doctrine,
ruling, assessment or arbitration award or similar order of any Governmental Authority.

“Merger Agreement” means the Agreement and Plan of Merger, dated as of December 21,
2010, as amended, by and among the Company, Bulls I Acquisition Corp., Bulls II Acquisition LLC,
CIFC Parent and Commercial Industrial Finance Corp.

“Original Agreement” means the Registration Rights Agreement, dated as of June 9,
2010, by and between the Company and Bounty Investments, LLC.

“Other Securities” has the meaning set forth in Section 2(d).

“Person” means any individual, corporation, partnership, limited liability company,
limited liability partnership, firm, joint venture, association, joint-stock company, trust,
unincorporated organization, Governmental Authority or other entity.

“Piggyback Notice” has the meaning set forth in Section 3(a).

“Piggyback Registration” has the meaning set forth in Section 3(a)

“Proceeding” means an action, claim, suit, investigation or proceeding (including,
without limitation, an investigation or partial proceeding, such as a deposition), whether
commenced or known to the Company to be threatened.

“Prospectus” means the prospectus included in a Registration Statement (including,
without limitation, a prospectus that includes any information previously omitted from a prospectus
filed as part of an effective registration statement in reliance upon Rule 430A promulgated under
the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration
Statement, and all other amendments and supplements to the Prospectus, including post-effective
amendments, and all material incorporated by reference or deemed to be incorporated by reference in
such Prospectus.

“Questionnaire” has the meaning set forth in Section 4(k).

“Registrable Securities” means (i) the Investor Shares, (ii) the Conversion Shares
issuable or issued upon the conversion of the Convertible Notes, (iii) the shares of Common Stock
issuable or issued upon the exercise of the Warrant or the conversion of the Preferred Stock, (iv)
any securities issued as (or issuable upon the conversion or exercise of any warrant, right or
other security that is issued as) a dividend, stock split, recapitalization or other distribution
with respect to, or in exchange for, or in replacement of, the securities referenced in
clauses (i), (ii), or (iii) above or this clause (iv); provided, however, that the
term “Registrable Securities” shall exclude in all cases any securities (1) sold or exchanged by a
Person pursuant to an effective registration statement under the Act or in compliance with
Rule 144, (2) that are Freely Tradable (it being understood that for purposes of determining
eligibility for resale under this clause (2), solely with respect to clause (i) of the definition
of Freely Tradable, no securities held by any Holder shall be considered Freely Tradable to the
extent such Holder reasonably determines that it is an affiliate (as defined under Rule 144) of the
Company), (3) that shall have ceased to be outstanding, or (4) the shares of Preferred Stock
issuable or issued upon the exercise of the Warrant. Notwithstanding the foregoing, Investor Shares
held by GECEII or its Affiliates shall be deemed to be Registrable Securities (even if Freely
Tradable) for purposes of Sections 2 and 3.

“Registration Default” has the meaning set forth in Section 2(b).

“Registration Default Date” has the meaning set forth in Section 2(b).

“Registration Default Period” has the meaning set forth in Section 2(b).

“Registration Statement” means a registration statement in the form required to
register the resale of the Registrable Securities, and including the Prospectus, amendments and
supplements to each such registration statement or Prospectus, including pre- and post-effective
amendments, all exhibits thereto, and all material incorporated by reference or deemed to be
incorporated by reference in such registration statement.

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such Rule.

“Rule 405” means Rule 405 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such Rule.

“Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such Rule.

“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such Rule.

“Rule 433” means Rule 433 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such Rule.

“Securities Act” means the Securities Act of 1933, as amended.

“Self-Regulatory Organization” means each national securities exchange in the United
States of America or other commission, board, agency or body that is charged with the supervision
or regulation of brokers, dealers, securities underwriting or trading, stock exchanges, commodities
exchanges, insurance companies or agents, investment companies or investment advisers, or to the
jurisdiction of which any party or any of their respective subsidiaries is otherwise subject.

“Special Interest” has the meaning set forth in Section 2(b).

“Super Majority Interest” means the holders of two-thirds (66 2/3%) of the Registrable
Securities.

“Suspension Period” has the meaning set forth in Section 2(a).

“Trading Day” means any day on which the Common Stock is traded on the Trading Market,
or, if there is no Trading Market, any Business Day.

“Trading Market” means the principal national securities exchange on which the Common
Stock is listed.

“WKSI” means a “well known seasoned issuer” as defined under Rule 405.

Section 2. Demand Registration and Piggyback Rights on Demand Registrations.

(a) Subject to Section 2(c), if at any time the Company receives a written request
from DFR Holdings, CIFC Parent or GECEII that the Company register Registrable Securities under the
Securities Act, the Company will prepare and file with the Commission, as promptly as reasonably
practicable but not later than the applicable Filing Date, a Registration Statement covering the
resale of all Registrable Securities that the Demanding Holder requests to be registered (each such
registration, a “Demand Registration”); provided, that the Company shall not be
required to register the Registrable Securities unless the Demanding Holder has requested to
include in such Registration at least the lesser of (A) 1,000,000 shares of Common Stock and (B) if
the Common Stock is then listed, the number of Registrable Securities having a fair market value
(based on the closing price of the Common Stock quoted on the Trading Market immediately preceding
the date the request is received by the Company) of $5,000,000. The Registration Statement
(i) shall be on Form S-3 (except if the Company is not then eligible to register for resale the
Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form for such purpose) and, if the Company is a WKSI as of the Filing Date, shall be an Automatic
Shelf Registration Statement and (ii) shall contain (except if otherwise requested by the Demanding
Holder or required pursuant to written comments received from the Commission upon a review of such
Registration Statement) the “Plan of Distribution” in substantially the form attached
hereto as Annex A. The Company will use its commercially reasonable efforts to cause the
Registration Statement to be declared effective or otherwise to become effective under the
Securities Act as soon as possible but, in any event, no later than the Effectiveness Date, and
will use its commercially reasonable efforts to keep the Registration Statement continuously
effective from the Effectiveness Date until the earliest to occur of (x) the date on which the
Demanding Holder notifies the Company in writing that all Registrable Securities included in such
Registration Statement have been sold in reliance thereon or that the offering for the sale thereof
(or any unsold portion thereof) has been abandoned, and (y) thirty (30) days following the date
that such Registration Statement was declared effective by the Commission (such period, the
“Effectiveness Period”). The Company shall promptly notify all other Holders of any demand
made by a Demanding Holder, and each such Holder who wishes to include all or a portion of such
Holder’s Registrable Securities in the Demand Registration shall so notify the Company within
fifteen (15) days after the receipt by the Holder of the notice from the Company. Upon any such
request, the Electing Holders shall be entitled to have their Registrable Securities included in
the Demand Registration, subject to Section 2(d). Neither the Company nor any other Person
(other than the Demanding Holder and any Electing Holders) shall be entitled to include Other
Securities in any Demand Registration without the prior written consent of the Demanding Holder.
Notwithstanding anything to the contrary in this Agreement, upon notice to the Holders, without
incurring or accruing any obligation to pay any Special Interest pursuant to (b), the
Company may suspend the use or effectiveness of the Registration Statement, or delay the Filing
Date, for up to thirty (30) consecutive days and up to ninety (90) days in the aggregate, in any
365-day period (a “Suspension Period”) if the Board of Directors of the Company determines
that there is a valid business purpose for extension, which valid business purpose shall include
without limitation plans for a registered public offering, an acquisition or other proposed or
pending corporate developments and similar events (it being agreed that the notice of the Extension
Period need not state the reason therefor); provided that (1) a Suspension Period shall not
prevent the Holders from requesting any Demand Registration or electing to participate in any
Piggyback Registration under Section 3, (2) a Suspension Period shall not apply to Holders
in any Piggyback Registration to the extent the Company has waived the Suspension Period with
respect to any registered offering of Other Securities for its own account or for the account of
any other Person, which offering gives rise to such Piggyback Registration and (3) a Suspension
Period may not be in effect, and may not commence, at any time during the period from and after the
date that the Convertible Notes are redeemed pursuant to Section 4 of the Convertible Note
Agreement through 5:00 p.m. New York City time on the date that is ten (10) consecutive Trading
Days after the date of such redemption. In the event the Company exercises its rights under the
preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice
referred to above, their use of the Prospectus relating to such Registration Statement in
connection with any sale or offer to sell Registrable Securities and not to sell any Registrable
Securities pursuant thereto until such Holder has been advised in writing by the Company that the
applicable Prospectus may be used or is effective (which notice the Company agrees to provide
promptly following the lapse of the event or circumstance giving rise to such suspension). Each
Holder shall keep confidential the fact of the delivery of the extension notice except as required
by applicable Law. If the Company delays any Filing Date pursuant to a Suspension Period, then the
Demanding Holder may withdraw the Demand Registration at any time prior to the filing of the
Registration Statement by providing written notice to the Company.

(b) If, with respect to any Registration Statement required by this Section 2:
(i) such Registration Statement is not filed on or prior to its Filing Date, (ii) such Registration
Statement is not declared effective by the Commission or does not otherwise become effective on or
prior to its required Effectiveness Date, (iii) the Company fails to file with the Commission a
request for acceleration with Rule 461 promulgated under the Securities Act, within five (5)
Trading Days of the date on which the Company is notified (orally or in writing, whichever is
earlier) by the Commission that such Registration Statement will not be reviewed or is not subject
to further review, or (iv) after its Effective Date, such Registration Statement ceases for any
reason to be effective and available to the Holders as to all Registrable Securities to which it is
required to cover at any time prior to the expiration of the Effectiveness Period (in each case,
except as specifically permitted herein with respect to any applicable Suspension Period and
subject to Section 2(d)) (any such failure or breach being referred to as a
“Registration Default,” and for purposes of clauses (i) or (ii) the date on which such
Registration Default occurs, and for purposes of clause (iii) the date on which such five (5)
Trading Day period is exceeded and for purposes of clause (iv) the date on which the Registration
Statement ceases to be effective and available, being referred to as the “Registration Default
Date” and each period from and including the Registration Default Date during which a
Registration Default has occurred and is continuing, a “Registration Default Period”),
then, during the Registration Default Period, in addition to any other rights available to the
Holders (including, without limitation, pursuant to Section 8(a)), the Company will pay a
special payment (collectively, “Special Interest”) to Holders (x) in respect of each
Convertible Note convertible into Conversion Shares that, when issued, will constitute Registrable
Securities (which, for the avoidance of doubt, shall be deemed to constitute Registrable Securities
to the extent such Holder reasonably determines that it is, or upon conversion of such Convertible
Notes would reasonably be expected to become, an affiliate (as defined under Rule 144) of the
Company), in an amount equal to one percent (1.0%) per annum of the principal amount of such
Convertible Note and, without duplication, (y) in respect of each Conversion Share issued upon
conversion of the Convertible Notes and that is a Registrable Security, in an amount equal to one
percent (1.0%) per annum of the quotient of one thousand dollars ($1,000) divided by the number of
Conversion Shares issued upon conversion of such Convertible Notes; provided that (A) no
Special Interest shall accrue or be payable in respect of the Investor Shares and (B) the
obligation to pay Special Interest in respect of a Demand Registration may be waived with respect
to all Registrable Securities covered thereby in the sole discretion of the applicable Demanding
Holder. Special Interest shall accrue from the applicable Registration Default Date until all
Registration Defaults have been cured and shall be payable quarterly in arrears on each January 1,
April 1, July 1 and October 1 following the applicable Registration Default Date to the record
holder of the applicable security on the date that is fifteen (15) days prior to such payment date,
until paid in full. Special Interest payable in respect of any Registration Default Period shall
be computed on the basis of a 360-day year consisting of twelve (12) thirty (30)-day months.
Special Interest shall be payable only with respect to a single Registration Default at any given
time, notwithstanding the fact that multiple Registration Defaults may have occurred and be
continuing.

(c) The Company shall not be required to effect a Demand Registration of Registrable
Securities pursuant to this Section 2 (x) at the request of DFR Holdings if the Company has
effected a total of two (2) Demand Registrations at the request of DFR Holdings, (y) at the request
of CIFC Parent if the Company has effected a total of two (2) Demand Registrations at the request
of CIFC Parent, or (z) at the request of GECEII if the Company has effected one (1) Demand
Registration at the request of GECEII, in each case in accordance with the terms of this
Section 2, and each Registration Statement filed upon such Demand Registration was declared
or ordered effective by the Commission and was maintained effective by the Company throughout the
Effectiveness Period as required by Section 2(a); provided further that,
for the avoidance of doubt, any Demand Registration that is delayed or interrupted due to a
Suspension Period, for which demand has been withdrawn in accordance with Section 2(a), or
otherwise not maintained available to the Demanding Holder and Electing Holders (subject to
Section 2(d)) at all times through the Effectiveness Period shall not constitute one (1) of
the Demand Registrations to which such Demanding Holder is entitled under this
Section 2(c).

(d) If the Demand Registration is an underwritten offering and if the managing underwriter or
underwriters for a Demand Registration that is to be an underwritten offering advises the Company
and the Demanding Holder in writing that it is their good faith opinion that the total amount of
Registrable Securities which the Demanding Holder desires to sell, taken together with all shares
of Common Stock or other equity securities of the Company (such Common Stock and other equity
securities (other than Registrable Securities) collectively, “Other Securities”), which the
Company and any other Persons having rights to participate in such registration intend to include
in such offering, exceeds the total number or aggregate dollar amount of such securities that can
be sold without having an adverse effect on the price, timing, distribution method or successful
offering of the Registrable Securities to be so included together with all Other Securities, then
there shall be included in such firm commitment underwritten offering the number or dollar amount
of Registrable Securities and such Other Securities that in the good faith opinion of such managing
underwriter or underwriters can be sold without so adversely affecting such offering, and such
number of Registrable Securities and Other Securities shall be allocated for inclusion as follows:
(i) first, all Registrable Securities being sold by the Demanding Holder and Electing Holders, pro
rata, based on the number of Registrable Securities that each such Holder has requested be included
in such Demand Registration; (ii) second, all Other Securities being sold by the Company; and
(iii) third, all Other Securities of any holders thereof requesting inclusion in such Demand
Registration, pro rata, based on the number of Other Securities that each such Person has requested
be included in such Demand Registration.

(e) Notwithstanding anything to the contrary herein, in no event shall the Company be required
to file or cause to be declared effective a Registration Statement providing for the resale of
Registrable Securities on a delayed or continuous basis pursuant to Rule 415 or otherwise for a
period longer than thirty (30) days.

Section 3. Piggyback Rights on Company or Third Party Registrations.

(a) Subject to the terms and conditions of this Agreement, if at any time after the date
hereof, the Company files a registration statement under the Securities Act with respect to an
offering of Other Securities, whether or not for sale for its own account (other than a
registration statement (i) on Form S-4, Form S-8 or any successor forms, (ii) filed solely in
connection with any employee benefit or dividend reinvestment plan or (iii) filed pursuant to a
Demand Registration in accordance with Section 2), then the Company shall use commercially
reasonably efforts to give written notice of such filing to the Holders at least ten (10) Business
Days before the anticipated filing date (or such later date as it becomes commercially reasonable
to provide such notice) (the “Piggyback Notice”). The Piggyback Notice and the contents
thereof shall be kept confidential by the Holders and their respective Affiliates and
representatives, and the Holders shall be responsible for breaches of confidentiality by their
respective Affiliates and representatives. The Piggyback Notice shall offer the Holders the
opportunity to include in such registration statement, subject to the terms and conditions of this
Agreement, the number of Registrable Securities as they may reasonably request (a “Piggyback
Registration”). Subject to the terms and conditions of this Agreement, the Company shall use
its commercially reasonable efforts to include in each such Piggyback Registration all Registrable
Securities with respect to which the Company has received from the Holders written requests for
inclusion therein within ten (10) Business Days following receipt of any Piggyback Notice by the
Holders, which request shall specify the maximum number of Registrable Securities intended to be
disposed of by such Electing Holders and the intended method of distribution. For the avoidance of
doubt and notwithstanding anything in this Agreement to the contrary, the Company may not commence
or permit the commencement of any sale of Other Securities for its own account or the account of
another Person that is not a Holder in a public offering to which this Section 3 applies
unless the Holders shall have received the Piggyback Notice in respect to such public offering not
less than ten (10) Business Days prior to the commencement of such sale of Other Securities. The
Electing Holders shall be permitted to withdraw all or part of the Registrable Securities from a
Piggyback Registration at any time at least two (2) Business Days prior to the effective date of
the registration statement relating to such Piggyback Registration. No Piggyback Registration
shall count towards the number of demand registrations that any Holder is entitled to make pursuant
to Section 2.

(b) If any Other Securities Registered in accordance with the procedures set forth in
Section 3(a) are to be sold in an underwritten offering, (1) the Company or other Persons
designated by the Company shall have the right to appoint the book-running, managing and other
underwriter(s) for such offering in their discretion and (2) the Electing Holders shall be
permitted to include all Registrable Securities requested to be included in such registration in
such underwritten offering on the same terms and conditions as such Other Securities proposed by
the Company or any third party to be included in such offering; provided, however,
that if such offering involves an underwritten offering and the managing underwriter or
underwriters of such underwritten offering advise the Company in writing that it is their good
faith opinion that the total amount of Registrable Securities requested to be so included, together
with all Other Securities that the Company and any other Persons having rights to participate in
such registration intend to include in such offering, exceeds the total number or dollar amount of
such securities that can be sold without having an adverse effect on the price, the timing or the
method of distribution of the Registrable Securities to be so included together with all Other
Securities, then there shall be included in such firm commitment underwritten offering the number
or dollar amount of Registrable Securities and such Other Securities that in the good faith opinion
of such managing underwriter or underwriters can be sold without so adversely affecting such
offering, and such number of Registrable Securities and Other Securities shall be allocated for
inclusion as follows: (x) to the extent such public offering is the result of a registration
initiated by the Company, (i) first, all Other Securities being sold by the Company, (ii) second,
the Registrable Securities as to which Registration has been requested by the Electing Holders, pro
rata, based on the number of Registrable Securities beneficially owned by the Electing Holders, and
(iii) third, all Other Securities of any holders thereof (other than the Company and the Electing
Holders) requesting inclusion in such registration, pro rata, based on the number of Other
Securities beneficially owned by each such holder of Other Securities or (y) to the extent such
public offering is the result of a registration by any Persons (other than the Company or the
Holders) exercising a contractual right to demand registration not included in this Agreement,
(i) first, all Other Securities owned by such Persons exercising the contractual right, pro rata,
based on the number of Other Securities beneficially owned by each such holder of Other Securities,
(ii) second, the Registrable Securities as to which Registration has been requested by the Electing
Holders, pro rata, based on the number of Registrable Securities beneficially owned by such
Electing Holders, (iii) third, all Other Securities being sold by the Company, and (iv) fourth, all
Other Securities requested to be included in such registration by other holders thereof (other than
the Company and the Holders), pro rata, based on the number of Other Securities beneficially owned
by each such holder of Other Securities.

Section 4. Registration Procedures. The procedures to be followed by the Company and
each selling Holder, and the respective rights and obligations of the Company and such Holders,
with respect to the preparation, filing and effectiveness of a Registration Statement, and the
distribution of Registrable Securities pursuant thereto, are as follows:

(a) The Company will, as promptly as practicable prior to the filing of a Registration
Statement or any related Prospectus or any amendment or supplement thereto, (i) furnish to the
Holders copies of all such documents proposed to be filed, which documents (other than those
incorporated by reference) will be subject to the reasonable review of such Holders and (ii) use
its reasonable efforts to address in each such document when so filed with the Commission such
comments as the Holders reasonably shall propose.

(b) The Company will use commercially reasonable efforts to: (i)  prepare and file with the
Commission such amendments, including post-effective amendments, and supplements to each
Registration Statement and the Prospectus used in connection therewith as may be necessary under
applicable Law with respect to the disposition of all Registrable Securities covered by such
Registration Statement continuously effective as to the applicable Registrable Securities for its
Effectiveness Period and prepare and file with the Commission such additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable
Securities; (ii) cause the related Prospectus to be amended or supplemented by any required
Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; and
(iii) respond as promptly as reasonably possible to any comments received from the Commission with
respect to each Registration Statement or any amendment thereto and, as promptly as reasonably
possible provide the Holders true and complete copies of all correspondence from and to the
Commission relating to such Registration Statement that pertains to the Holders as “selling
stockholders” but not any comments that would result in the disclosure to the Holders of material
and non-public information concerning the Company.

(c) The Company will comply in all material respects with the provisions of the Securities Act
and the Exchange Act with respect to the Registration Statements and the disposition of all
Registrable Securities covered by each Registration Statement.

(d) The Company will notify the Holders as promptly as reasonably practicable (and, in the
case of (i)(A) below, not less than three (3) Trading Days prior to such filing) and (if requested
by any such Person) confirm such notice in writing no later than one (1) Trading Day following the
day: (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a
Registration Statement is proposed to be filed; (B) when the Commission notifies the Company
whether there will be a “review” of such Registration Statement and whenever the Commission
comments in writing on such Registration Statement (in which case the Company shall provide true
and complete copies thereof and all written responses thereto to each of the Holders that pertain
to the Holders as “selling stockholders” or to the Plan of Distribution, but not information which
the Company believes would constitute material and non-public information); and (C) with respect to
each Registration Statement or any post-effective amendment, when the same has been declared
effective; (ii) of any request by the Commission or any other Federal or state governmental
authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information that pertains to the Holders as “selling stockholders” or the Plan of Distribution;
(iii) of the issuance by the Commission of any stop order suspending the effectiveness of a
Registration Statement covering any or all of the Registrable Securities or the initiation of any
Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Registrable
Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for
such purpose; and (v) of the occurrence of (but not the nature or details concerning) any event or
passage of time that makes the financial statements included in a Registration Statement ineligible
for inclusion therein or any statement made in such Registration Statement or Prospectus or any
document incorporated or deemed to be incorporated therein by reference untrue in any material
respect or that requires any revisions to such Registration Statement, Prospectus or other
documents so that, in the case of such Registration Statement or the Prospectus, as the case may
be, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading.

(e) The Company will use commercially reasonable efforts to avoid the issuance of, or, if
issued, obtain the withdrawal of (i) any order suspending the effectiveness of a Registration
Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of
the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment, or if
any such order or suspension is made effective during any Suspension Period, as soon as reasonably
practicable after the Suspension Period is over.

(f) During the Effectiveness Period, the Company will furnish to each Holder, without charge,
at least one (1) conformed copy of each Registration Statement and each amendment thereto and all
exhibits to the extent requested by such Person (including those incorporated by reference)
promptly after the filing of such documents with the Commission.

(g) The Company will promptly deliver to each Holder, without charge, as many copies of each
Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement
thereto as such Persons may reasonably request during the Effectiveness Period. The Company hereby
consents to the use of such Prospectus and each amendment or supplement thereto by each of the
selling Holders in connection with the offering and sale of the Registrable Securities covered by
such Prospectus and any amendment or supplement thereto.

(h) The Company will, prior to any public offering of Registrable Securities, use commercially
reasonable efforts to register or qualify or cooperate with the selling Holders in connection with
the registration or qualification (or exemption from such registration or qualification) of such
Registrable Securities for offer and sale under the applicable state securities or Blue Sky Laws of
those jurisdictions within the United States as any Holder reasonably requests in writing to keep
each such registration or qualification (or exemption therefrom) effective during the Effectiveness
Period and to do any and all other acts or things necessary or advisable to enable the disposition
in such jurisdictions of the Registrable Securities covered by the Registration Statements;
provided, that the Company will not be required to (i) qualify generally to do business or
as a dealer in securities in any jurisdiction where it is not then so qualified or (ii) take any
action which would subject the Company to general service of process or any material tax in any
such jurisdiction where it is not then so subject.

(i) The Company will cooperate with the Holders to facilitate the timely preparation and
delivery of certificates representing Registrable Securities to be delivered to a transferee
pursuant to the Registration Statements, which certificates shall be free, to the extent permitted
by the Merger Agreement, the Acquisition Agreement, the Asset Purchase Agreement, the Investment
Agreement, the Warrant and the Convertible Note Agreement and/or the Convertible Notes, of all
restrictive legends, and to enable such Registrable Securities to be in such denominations and
registered in such names as any such Holders may request. In connection therewith, if required by
the Company’s transfer agent, the Company will promptly after the effectiveness of the Registration
Statement cause an opinion of counsel as to the effectiveness of the Registration Statement to be
delivered to and maintained with its transfer agent, together with any other authorizations,
certificates and directions required by the transfer agent which authorize and direct the transfer
agent to issue such Registrable Securities without legend upon sale by the holder of such shares of
Registrable Securities under the Registration Statement.

(j) Upon the occurrence of any event contemplated by Section 4(d)(v), as promptly as
reasonably possible, the Company will prepare a supplement or amendment, including a post-effective
amendment, if required by applicable Law, to the affected Registration Statements or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by
reference, and file any other required document so that, as thereafter delivered, no Registration
Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading.

(k) In connection with filing any Registration Statement, the Company may require each Holder
that wishes to include Registrable Securities in such Registration Statement to furnish to the
Company a certified statement as to the securities of the Company (including shares of Common Stock
issuable upon conversion of Convertible Notes) beneficially owned by such Holder and any Affiliate
thereof substantially in the form of Exhibit A hereto (the “Questionnaire”) for use
in connection with the Registration Statement at least ten (10) Trading Days prior to the filing of
the Registration Statement. Each Holder further agrees that it shall not be entitled to be named
as a selling securityholder in a Registration Statement or use the Prospectus for offers and
resales of Registrable Securities at any time, unless such Holder has returned to the Company a
completed and signed Questionnaire. Each Holder acknowledges and agrees that the information in
the Questionnaire will be used by the Company in the preparation of the Registration Statement and
hereby consents to the inclusion of such information in the Registration Statement. The Company
agrees to periodically update the Prospectus upon request to add any Holders who have delivered a
Questionnaire since initial filing or the last such update as selling securityholders in the
Prospectus.

(l) The Holders may distribute the Registrable Securities by means of an underwritten
offering; provided that (i) the Demanding Holder provides written notice to the Company of
its intention to distribute Registrable Securities by means of an underwritten offering, (ii) the
managing underwriter or underwriters thereof shall be designated by the Demanding Holder
(provided, however, that such designated managing underwriter or underwriters shall
be reasonably acceptable to the Company), (iii) each Holder participating in such underwritten
offering agrees to sell such Holder’s Registrable Securities on the basis provided in any
underwriting arrangements approved by the persons entitled selecting the managing underwriter or
underwriters hereunder and (iv) each Holder participating in such underwritten offering completes
and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other
documents reasonably required under the terms of such underwriting arrangements. The Company
hereby agrees with each Holder that, in connection with any underwritten offering in accordance
with the terms hereof, it will negotiate in good faith and execute all indemnities, underwriting
agreements and other documents reasonably required under the terms of such underwriting
arrangements, including using all commercially reasonable efforts to procure customary legal
opinions and auditor “comfort” letters.

(m) In the event the Holders seek to complete an underwritten offering, for a reasonable
period prior to the filing of any Registration Statement, and throughout the Effectiveness Period,
the Company will make available upon reasonable notice at the Company’s principal place of business
or such other reasonable place for inspection by the managing underwriter or underwriters selected
in accordance with Section 4(l), such financial and other information and books and records
of the Company, and cause the officers, employees, counsel and independent certified public
accountants of the Company to respond to such inquiries, as shall be reasonably necessary (and in
the case of counsel, not violate an attorney-client privilege in such counsel’s reasonable belief)
in the judgment of legal counsel for such managing underwriter or underwriters, to conduct a
reasonable investigation within the meaning of Section 11 of the Securities Act; provided,
however, that the foregoing inspection and information gathering on behalf of the Holders
(and any managing underwriter or underwriters) shall be conducted by legal counsel to the Holders
(and legal counsel to such managing underwriter or underwriters); and provided
further that each such party shall be required to maintain in confidence and not to
disclose to any other Person any information or records reasonably designated by the Company as
being confidential, until such time as (A) such information becomes a matter of public record
(whether by virtue of its inclusion in the Registration Statement or in any other manner other than
through the release of such information by any Person afforded access to such information pursuant
hereto), or (B) such Person shall be required so to disclose such information pursuant to a
subpoena or order of any court or other governmental agency or body having jurisdiction over the
matter (subject to the requirements of such order, and only after such Person shall have given the
Company prompt prior written notice of such requirement so that the Company may seek to object to
such subpoena or order, or to make such disclosure subject to a protective order or confidentiality
agreement).

(n) DFR Holdings hereby acknowledges the restrictions on the transfer of the DFR Holdings
Shares, the Convertible Notes and the Conversion Shares as set forth in the Acquisition Agreement,
the Stockholders Agreement and/or the Convertible Note Agreement, and expressly acknowledges and
agrees that nothing herein shall be deemed to permit any assignment, transfer or other disposition
of Registrable Securities in violation of the terms of the Acquisition Agreement, the Stockholders
Agreement, or the Convertible Note Agreement, as applicable. CIFC Parent hereby acknowledges the
restrictions on the transfer of the CIFC Shares as set forth in the Merger Agreement and the
Stockholders Agreement, and expressly acknowledges and agrees that nothing herein shall be deemed
to permit any assignment, transfer or other disposition of Registrable Securities in violation of
the terms of the Merger Agreement or the Stockholders Agreement. GECEII hereby acknowledges the
restrictions on the transfer of the GECEII Shares, the Warrant and the Warrant Shares as set forth
in the Asset Purchase Agreement, the Investment Agreement and/or the Warrant, and expressly
acknowledges and agrees that nothing herein shall be deemed to permit any assignment, transfer or
other disposition of Registrable Securities in violation of the terms of the Asset Purchase
Agreement, the Investment Agreement or the Warrant, as applicable.

Section 5. Registration Expenses. All fees and expenses incident to the Company’s
performance of or compliance with its obligations under this Agreement (excluding any underwriting
discounts and selling commissions, but including all legal fees and expenses of one (1) legal
counsel to the Holders) shall be borne by the Company whether or not any Registrable Securities are
sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing
sentence shall include, without limitation, (i) all registration and filing fees (including,
without limitation, fees and expenses (A) with respect to filings required to be made with the
Trading Market, and (B) in compliance with applicable state securities or Blue Sky Laws),
(ii) printing expenses (including, without limitation, expenses of printing certificates for
Registrable Securities and of printing prospectuses if the printing of prospectuses is reasonably
requested by the holders of a majority of the Registrable Securities included in the Registration
Statement), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of
counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such
insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company
shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any
annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. For the avoidance of doubt, each
Holder shall pay all underwriting and placement discounts and commissions, agency and placement
fees, brokers’ commissions and transfer taxes, if any, relating to the sale or disposition of such
Holder’s Registrable Securities. In addition to the foregoing, the Company shall pay the
reasonable legal fees and expenses of the single counsel to the Holders in connection with the
Registration Statement (not to exceed $50,000 in the aggregate); provided, however,
if the Holders reasonably determine that local counsel is required in connection with the
Registration Statement, then the Company shall be obligated to pay such reasonable legal fees and
expense as well (not to exceed $15,000 in the aggregate).

Section 6. Indemnification.

(a) Indemnification by the Company. The Company will, notwithstanding any termination
of this Agreement, indemnify and hold harmless each Holder, the officers, directors, agents,
partners, members, stockholders and employees of each of them, each Person who controls any such
Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act)
and the officers, directors, agents and employees of each such controlling Person, to the fullest
extent permitted by applicable Law, from and against any and all losses, claims, damages,
liabilities, costs (including, without limitation, reasonable costs of preparation and reasonable
attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or
relating to any untrue or alleged untrue statement of a material fact contained in any Registration
Statement, any Prospectus or any form of prospectus (including, without limitation, any “issuer
free writing prospectus” as defined in Rule 433) or in any amendment or supplement thereto or in
any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a
material fact required to be stated therein or necessary to make the statements therein (in the
case of any Prospectus or form of prospectus (including, without limitation, any “issuer free
writing prospectus” as defined in Rule 433) or supplement thereto, in light of the circumstances
under which they were made) not misleading, except to the extent, but only to the extent, that such
untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon
information regarding such Holder furnished in writing to the Company by such Person expressly for
use therein pursuant to Section 4(k). The Company shall notify the Holders promptly of the
institution, threat or assertion of any Proceeding of which the Company is aware in connection with
the transactions contemplated by this Agreement.

(b) Indemnification by Holders. Each Holder shall, notwithstanding any termination of
this Agreement, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of
Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
agents or employees of such controlling Persons, to the fullest extent permitted by applicable Law,
from and against all Losses, as incurred, arising solely out of or based solely upon any untrue
statement of a material fact contained in any Registration Statement, any Prospectus, or any form
of prospectus (including, without limitation, any “issuer free writing prospectus” as defined in
Rule 433), or in any amendment or supplement thereto, or arising solely out of or based solely upon
any omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus, or any form of prospectus (including, without limitation,
any “issuer free writing prospectus” as defined in Rule 433) or supplement thereto, in light of the
circumstances under which they were made) not misleading to the extent, but only to the extent,
that such untrue statements or omissions are based solely upon information regarding such Holder
furnished in writing to the Company by such Holder in the Questionnaire or otherwise expressly for
use therein. In no event shall the liability of any selling Holder hereunder be greater in amount
than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable
Securities giving rise to such indemnification obligation.

(c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or
asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such
Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
“Indemnifying Party”) in writing, and the Indemnifying Party shall be permitted to assume
the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified
Party and the payment of all fees and expenses incurred in connection with defense thereof;
provided, that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and
only) to the extent that it shall be finally determined by a court of competent jurisdiction (which
determination is not subject to appeal or further review) that such failure shall have proximately
and materially adversely prejudiced the Indemnifying Party.

An Indemnified Party shall have the right to employ separate counsel in any such Proceeding
and to participate in the defense thereof, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to
assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such
Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and such Indemnified Party shall have been advised by counsel that a conflict of interest is likely
to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party
(in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects
to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall
not have the right to assume the defense thereof and such counsel shall be at the expense of the
Indemnifying Party); provided that the Indemnifying Party shall not be liable for the fees
and expenses of more than one separate firm of attorneys at any time for all Indemnified Parties.
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected
without its written consent, which consent shall not be unreasonably withheld, conditioned or
delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a
party, unless such settlement includes an unconditional release of such Indemnified Party from all
liability on claims that are the subject matter of such Proceeding.

Subject to the terms and conditions of this Agreement, all fees and expenses of the
Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such Proceeding in a manner not inconsistent with this
Section) shall be paid to the Indemnified Party, as incurred, promptly upon receipt of written
notice thereof to the Indemnifying Party (regardless of whether it is ultimately determined that an
Indemnified Party is not entitled to indemnification hereunder; provided that the
Indemnified Party shall promptly reimburse the Indemnifying Party for all such fees and expenses to
the extent it is finally judicially determined that such Indemnified Party is not entitled to
indemnification hereunder).

(d) Contribution. If a claim for indemnification under Section 6(a)or
Section 6(b) is unavailable to an Indemnified Party (by reason of public policy or
otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall
contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in
such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and
Indemnified Party in connection with the actions, statements or omissions that resulted in such
Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things,
whether any action in question, including any untrue or alleged untrue statement of a material fact
or omission or alleged omission of a material fact, has been taken or made by, or relates to
information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such action,
statement or omission. The amount paid or payable by a party as a result of any Losses shall be
deemed to include, subject to the limitations set forth in Section 6(c), any reasonable
attorneys’ or other reasonable fees or expenses incurred by such party in connection with any
Proceeding to the extent such party would have been indemnified for such fees or expenses if the
indemnification provided for in this Section was available to such party in accordance with its
terms.

The parties hereto agree that it would not be just and equitable if contribution pursuant to
this Section 6(d) were determined by pro rata allocation or by any other method of
allocation that does not take into account the equitable considerations referred to in the
immediately preceding paragraph. Notwithstanding the provisions of this Section 6(d), no
Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by
which the proceeds actually received by such Holder from the sale of the Registrable Securities
subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation.

The indemnity and contribution agreements contained in this Section are in addition to any
liability that the Indemnifying Parties may have to the Indemnified Parties and are not in
diminution or limitation of the indemnification provisions under the Acquisition Agreement, Merger
Agreement or Asset Purchase Agreement, as applicable.

Section 7. Facilitation of Sales Pursuant to Rule 144. To the extent it shall be
required to do so under the Exchange Act, the Company shall timely file the reports required to be
filed by it under the Exchange Act or the Securities Act (including the reports under Sections 13
and 15(d) of the Exchange Act referred to in subparagraph (c)(1) of Rule 144), and shall take such
further action as any Holder may reasonably request, all to the extent required from time to time
to enable the Holders to sell Registrable Securities without registration under the Securities Act
within the limitations of the exemption provided by Rule 144. Upon the request of any Holder in
connection with that Holder’s sale pursuant to Rule 144, the Company shall deliver to such Holder a
written statement as to whether it has complied with such requirements.

Section 8. Miscellaneous.

(a) Termination. The rights granted under this Agreement shall automatically
terminate upon the earlier of (i) such time as there are no outstanding Registrable Securities and
(ii) the date and time at which all of the Registrable Securities are Freely Tradable.

(b) Specific Performance. The Company and each Holder acknowledge that each party
would not have an adequate remedy at law for money damages in the event that any of the covenants
hereunder have not been performed in accordance with their terms, and therefore agree that each
other party hereto shall be entitled to specific enforcement of the terms hereof and any other
equitable remedy to which such party may be entitled. Each of the parties hereby waives (i) any
defenses in any action for specific performance, including the defense that a remedy at law would
be adequate and (ii) any requirement under any Law to post a bond or other security as a
prerequisite to obtaining equitable relief.

(c) Compliance. Subject to the Company’s compliance with its obligations set forth
under Section 4, each Holder covenants and agrees that it will comply with the prospectus
delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is
available) in connection with sales of Registrable Securities pursuant to the Registration
Statement and shall sell the Registrable Securities only in accordance with a method of
distribution described in the Registration Statement.

(d) Discontinued Disposition. Each Holder agrees by its acquisition of such
Registrable Securities that, upon receipt of a notice from the Company of the occurrence of any
event of the kind described in Section 4(d), such Holder will forthwith discontinue
disposition of such Registrable Securities under the Registration Statement until such Holder’s
receipt of the copies of the supplemented Prospectus and/or amended Registration Statement or until
it is advised in writing by the Company that the use of the applicable Prospectus may be resumed,
and, in either case, has received copies of any additional or supplemental filings that are
incorporated or deemed to be incorporated by reference in such Prospectus or Registration
Statement. The Company may provide appropriate stop orders to enforce the provisions of this
paragraph.

(e) Amendments and Waivers.

(i) This Agreement may not be amended, altered or modified and no provision of
this Agreement may be waived or amended except by written instrument executed by a
Super Majority Interest and the Company; provided that (A) any requirement
hereunder in respect of a Demand Registration (including any obligation to pay
Special Interest in respect thereof) may be waived or modified with respect to all
Registrable Securities covered thereby in a written instrument signed by the Company
and the applicable Demanding Holder, and (B) prior to any withdrawal by GECEII in
accordance with clause (ii) below, the prior written consent of GECEII shall be
required with respect to any amendment, alteration or modification of this Agreement
that would, directly or indirectly, (x) reduce the number of Demand Registrations to
which GECEII is entitled under this Agreement, or (y) prevent GECEII from
participating in a Piggyback Registration.

(ii) In the event of any amendment to this Agreement not consented to by
GECEII, GECEII shall be entitled to withdraw from this Agreement (it being
understood that the foregoing withdrawal right shall not permit any amendment that
would otherwise require the prior written consent of GECEII pursuant to clause
(i)(B) above). No such withdrawal shall affect GECEII’s or the Company’s
obligations with respect to liabilities incurred prior to withdrawal.

(iii) The failure by any party hereto to enforce at any time any of the
provisions of this Agreement shall in no way be construed to be a waiver of any such
provision nor in any way to affect the validity of this Agreement or any part hereof
or the right of such party thereafter to enforce each and every such provision. No
waiver of any breach of or non-compliance with this Agreement shall be held to be a
waiver of any other or subsequent breach or non-compliance. Any waiver made by any
party hereto in connection with this Agreement shall not be valid unless agreed to
in writing by such party.

(f) Notices. Any and all notices or other communications or deliveries required or
permitted to be provided hereunder shall be in writing and shall be deemed given and effective
(a) on the first (1st) Business Day after being sent, prepaid, by nationally recognized
overnight courier that issues a receipt or other confirmation of delivery, (b) when sent, if sent
by electronic mail before 5:00 p.m. on a Business Day at the location of receipt and otherwise the
next following Business Day. Any party may change the address to which Notices under this
Agreement are to be sent to it by giving written notice of a change of address in the manner
provided in this Agreement for giving Notice. The address for such notices and communications
shall be as follows:

	 	 	 
	If to the Company:
	 	CIFC Corp.

250 Park Avenue, 4th Floor

New York, NY 10177

Attention: Robert C. Milton III

Email: rmilton@cifc.com

 

	With a copy to:
	 	Goodwin Procter LLP

53 State Street

Boston, MA 02109

Attention: John Mutkoski, Esq.; Amber Dolman, Esq.

E-mail: jmutkoski@goodwinprocter.com;

adolman@goodwinprocter.com

 

	If to DFR Holdings:
	 	DFR Holdings, LLC

c/o Columbus Nova

900 Third Avenue, 19th Floor

New York, NY 10022

Attention: Paul Lipari

Email: plipari@columbusnova.com

 

	With a copy to:
	 	Latham & Watkins LLP

885 Third Avenue

New York, NY 10022

Attention: James C. Gorton, Esq.

E-mail Address: james.gorton@lw.com

 

	If to CIFC Parent:
	 	CIFC Parent Holdings LLC

c/o Charlesbank Capital Partners, LLC

200 Clarendon Street, 54th Floor

Boston, MA 02116

Attention: Tim R. Palmer

E-mail: tpalmer@charlesbank.com

 

	With a copy to:
	 	Goodwin Procter LLP

135 Commonwealth Drive

Menlo Park, CA 94025

Attention: Kevin M. Dennis, Esq.

E-mail: kdennis@goodwinprocter.com

 

	If to GECEII:
	 	GE Capital Equity Investments, Inc.

201 Merritt 7

Norwalk, CT 06856

Attention: CIFC Account Manager

E-mail: equity.portfolio@ge.com

 

	With a copy to:
	 	Allen & Overy LLP

1221 Avenue of the Americas

New York, NY 10020

Attention: Eric S. Shube, Esq.

E-mail: eric.shube@allenovery.com

 

	If to any other Person

who is then the

registered Holder:
	 	To the address of such Holder as it appears in the

applicable register for the Registrable Securities,

or after delivery of a Questionnaire by such Holder,

as provided in such Questionnaire or such other

address as may be designated in writing hereafter, in

the same manner, by such Person.

 

(g) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and permitted assigns of each of the parties and shall inure to the
benefit of each Holder; provided, however, that nothing herein shall be deemed to
permit any assignment, transfer or other disposition of Registrable Securities in violation of the
terms of (i) in the case of DFR Holdings, the Acquisition Agreement, the Stockholders Agreement or
the Convertible Note Agreement, (ii) in the case of CIFC Parent, the Merger Agreement or the
Stockholders Agreement and (iii) in the case of GECEII, the Asset Purchase Agreement, the
Investment Agreement or the Warrant. The Company may not assign its rights or obligations
hereunder without the prior written consent of the other parties hereto (other than by operation of
merger).

(h) Execution and Counterparts. This Agreement may be executed in counterparts
(including by facsimile or other electronic transmission), each of which shall be deemed an
original and each of which shall constitute one and the same instrument.

(i) Governing Law. This Agreement shall be governed by and construed in accordance
with the Laws of the State of New York without regard to choice of laws or conflicts of laws
provisions thereof that would require the application of the laws of any other jurisdiction.

(j) Consent to Jurisdiction. Each party to this Agreement, by its execution hereof,
(a) hereby irrevocably consents and agrees that any action, suit or proceeding arising in
connection with any disagreement, dispute, controversy or claim, in whole or in part, arising out
of, related to, based upon or in connection with this Agreement or the subject matter hereof shall
be brought only in the courts of the State Courts of the State of New York, New York County or the
United States District Court located in the State of New York, New York County, (b) hereby waives
to the extent not prohibited by applicable Law, and agrees not to assert, by way of motion, as a
defense or otherwise, in any such action, any claim that it is not subject personally to the
jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that any such action brought in one of the above-named courts should be dismissed on
grounds of forum non conveniens, should be transferred to any court other than one of the
above-named courts, or should be stayed by reason of the pendency of some other proceeding in any
other court other than one of the above-named courts, or that this Agreement or the subject matter
hereof may not be enforced in or by such court and (c) hereby agrees not to commence any such
action other than before one of the above-named courts nor to make any motion or take any other
action seeking or intending to cause the transfer or removal of any such action to any court other
than one of the above-named courts whether on the grounds of forum non conveniens or otherwise.
Each party hereby (i) consents to service of process in any such action in any manner permitted by
New York law, (ii) agrees that service of process made in accordance with clause (i) or made by
registered or certified mail, return receipt requested, at its address specified pursuant to
Section 8(f), shall constitute good and valid service of process in any such action, and
(iii) waives and agrees not to assert (by way of motion, as a defense, or otherwise) in any such
action any claim that service of process made in accordance with clause (i) or (ii) does not
constitute good and valid service of process.

(k) Severability. If any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in
full force and effect and shall in no way be affected, impaired or invalidated, and the parties
hereto shall use their reasonable efforts to find and employ an alternative means to achieve the
same or substantially the same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the parties that they
would have executed the remaining terms, provisions, covenants and restrictions without including
any of such that may be hereafter declared invalid, illegal, void or unenforceable.

(l) Entire Agreement. This Agreement, including any Schedules, Exhibits, Annexes,
certificates and lists referred to herein, any documents executed by the parties simultaneously
herewith or pursuant thereto constitute the entire understanding and agreement of the parties
hereto with respect to the subject matter hereof and supersedes all other prior agreements and
understandings, written or oral, between the parties with respect to such subject matter (including
without limitation, the A&R Agreement and Original Agreement). Each of the Company, CIFC Parent
and DFR Holdings hereby agrees, approves and consents, by its signature hereto, that the A&R
Agreement be, and hereby is, amended and restated in its entirety to read as set forth herein.

(m) Headings; Section References. The headings in this Agreement are for convenience
of reference only and shall not limit or otherwise affect the meaning hereof. Unless otherwise
stated, references to Sections, Schedules and Exhibits are to the Sections, Schedules and Exhibits
of this Agreement.

(n) Delays or Omissions. No delay or omission to exercise any right, power, or remedy
accruing to any party under this Agreement shall impair any such right, power, or remedy of such
party, nor shall it be construed to be a waiver of or acquiescence to any breach or default, or of
or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach
or default be deemed a waiver of any other breach or default. All remedies, either under this
Agreement or by Law or otherwise afforded to any holder, shall be cumulative and not alternative.

(o) Mutual Drafting; Interpretation. Each party hereto has participated in the
drafting of this Agreement, which each such party acknowledges is the result of extensive
negotiations between the parties. If an ambiguity or question of intent or interpretation arises,
this Agreement shall be construed as if drafted jointly by the parties, and no presumption or
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provision.

[THIS SPACE LEFT BLANK INTENTIONALLY]

3

4

IN WITNESS WHEREOF, the parties have executed this Amended and Restated Registration Rights
Agreement as of the date first written above.

	 	 	 
	 	 	COMPANY
	 	 	CIFC CORP.                                                         
	 	 	By: /s/ Robert C. Milton III

	 	 	 

	 	 	Name: Robert C. Milton, III        

	 	 	Title: Secretary and General Counsel

	 	 	 

	  
	 	INVESTORS:

	 	 	DFR HOLDINGS, LLC

	 	 	By: /s/ Andrew Intrater

	 	 	 

	 	 	Name: Andrew Intrater

	  
	 	Title: Manager

	 	 	   

	 	 	CIFC PARENT HOLDINGS LLC

	 	 	By: /s/ Michael Eisenson

	 	 	 

	  
	 	Name: Michael Eisenson

	 	 	Title: Director

	 	 	  

	 	 	GE CAPITAL EQUITY INVESTMENTS, INC.

	 	 	By: /s/ Shin Kimura

	 	 	 

	 	 	Name: Shin Kimura

	  
	 	Title: Vice President

5

ANNEX A

PLAN OF DISTRIBUTION

The holders of Securities (defined below) selling or otherwise disposing of such Securities
pursuant hereto (the “Selling Securityholders”) and any of their pledgees, donees,
transferees, assignees or other successors-in-interest may, from time to time, sell, transfer or
otherwise dispose of any or all of their shares of common stock of the Company or other securities
of the Company included for public offering in this prospectus (collectively, “Securities”)
or interests in Securities on any stock exchange, market or trading facility on which the
Securities are traded or in private transactions. These dispositions may be at fixed prices, at
prevailing market prices at the time of sale, at prices related to the prevailing market price, at
varying prices determined at the time of sale, or at negotiated prices. The Selling
Securityholders may use one or more of the following methods when disposing of the Securities or
interests therein:

	 	•	 	ordinary brokerage transactions and transactions in which the broker-dealer solicits
purchasers;

	 	•	 	block trades in which the broker-dealer will attempt to sell the Securities as agent
but may position and resell a portion of the block as principal to facilitate the
transaction;

	 	•	 	purchases by a broker-dealer as principal and resale by the broker-dealer for its
account;

	 	•	 	an exchange distribution in accordance with the rules of the applicable exchange;

	 	•	 	privately negotiated transactions;

	 	•	 	short sales entered into after the effective date of the registration statement of
which this prospectus is a part;

	 	•	 	through the writing or settlement of options or other hedging transactions, whether
through an options exchange or otherwise;

	 	•	 	broker-dealers may agree with the Selling Securityholders to sell a specified number
of such Securities at a stipulated price per share;

	 	•	 	a combination of any such methods of disposition; and

	 	•	 	any other method permitted pursuant to applicable law.

The Selling Securityholders may also sell Securities under Rule 144 under the Securities Act,
if available, rather than under this prospectus.

Broker-dealers engaged by the Selling Securityholders may arrange for other broker-dealers to
participate in sales. Broker-dealers may receive commissions or discounts from the Selling
Securityholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the
purchaser) in amounts to be negotiated. The Selling Securityholders do not expect these
commissions and discounts to exceed what is customary in the types of transactions involved.

The Selling Securityholders may from time to time pledge or grant a security interest in some
or all of the Securities owned by them and, if they default in the performance of their secured
obligations, the pledgees or secured parties may offer and sell Securities from time to time under
this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable
provision of the Securities Act of 1933 amending the list of Selling Securityholders to include the
pledgee, transferee or other successors in interest as Selling Securityholders under this
prospectus.

Upon the Company being notified in writing by a Selling Securityholder that any material
arrangement has been entered into with a broker-dealer for the sale of Securities through a block
trade, special offering, exchange distribution or secondary distribution or a purchase by a broker
or dealer, a supplement to this prospectus will be filed, if required, pursuant to
Rule 424(b) under the Securities Act, disclosing (i) the name of each such Selling Securityholder
and of the participating broker-dealer(s), (ii) the number of Securities involved, (iii) the price
at which such Securities were sold, (iv) the commissions paid or discounts or concessions allowed
to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any
investigation to verify the information set out or incorporated by reference in this prospectus,
and (vi) other facts material to the transaction. In addition, upon the Company being notified in
writing by a Selling Securityholder that a donee or pledge intends to sell more than 500
Securities, a supplement to this prospectus will be filed if then required in accordance with
applicable securities law.

The Selling Securityholders also may transfer the Securities in other circumstances, in which
case the transferees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.

In connection with the sale of Securities or interests in Securities, the Selling
Securityholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the Common Stock in the course of hedging
the positions they assume. The Selling Securityholders may also sell Securities of Common Stock
short and deliver these securities to close out their short positions, or loan or pledge the Common
Stock to broker-dealers that in turn may sell these securities. The Selling Securityholders may
also enter into option or other transactions with broker-dealers or other financial institutions or
the creation of one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of Securities offered by this prospectus, which Securities such
broker-dealer or other financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction).

The Selling Securityholders may enter into derivative transactions with third parties, or sell
securities not covered by this prospectus to third parties in privately negotiated transactions.
If the applicable prospectus supplement indicates, in connection with those derivatives, the third
parties may sell securities covered by this prospectus and the applicable prospectus supplement,
including in short sale transactions. If so, the third party may use securities pledged by the
Selling Securityholders or borrowed from the Selling Securityholders or others to settle those
sales or to close out any related open borrowings of stock, and may use securities received from
the Selling Securityholders in settlement of those derivatives to close out any related open
borrowings of stock. The third party in such sale transactions will be an underwriter and, if not
identified in this prospectus, will be identified in the applicable prospectus supplement (or a
post-effective amendment).

The Company has advised the Selling Securityholders that they are required to comply with
Regulation M promulgated under the Securities and Exchange Act during such time as they may be
engaged in a distribution of the Securities. The foregoing may affect the marketability of the
Securities.

The Company is required to pay all fees and expenses incident to the registration of the
Securities. The Company has agreed to indemnify the Selling Securityholders against certain
losses, claims, damages and liabilities, including liabilities under the Securities Act or
otherwise.

6

EXHIBIT A

FORM OF

SELLING SECURITYHOLDER QUESTIONNAIRE

Reference is made to that certain Second Amended and Restated Registration Rights Agreement (the
“Registration Rights Agreement”), dated as of September 24, 2012, by and among CIFC Corp.,
(the “Company”), DFR Holdings, LLC (“DFR Holdings”), CIFC Parent Holdings LLC
(“CIFC Parent”) and GE Capital Equity Investments, Inc. (“GECEII”). Capitalized
terms used and not defined herein shall have the meanings given to such terms in the Registration
Rights Agreement.

The undersigned Holder (the “Selling Securityholder”) of the Registrable Securities is
providing this Selling Securityholder Questionnaire pursuant to Section 4(k) of the
Registration Rights Agreement. The Selling Securityholder, by signing and returning this Selling
Securityholder Questionnaire, understands that it will be bound by the terms and conditions of this
Selling Securityholder Questionnaire and the Registration Rights Agreement. The Selling
Securityholder hereby acknowledges its indemnity obligations pursuant to Section 6(b) of
the Registration Rights Agreement.

7

The Selling Securityholder provides the following information to the Company and represents
and warrants that such information is accurate and complete:

	(1)	 	(a) Full Legal Name of Selling Securityholder:

	 	(b)	 	Full Legal Name of Registered Holder (if not the same as (a) above) through
which Registrable Securities listed in (3) below are held:

	 	(c)	 	Full Legal Name of DTC Participant (if applicable and if not the same as
(b) above) through which Registrable Securities listed in (3) below are held:

	(2)	 	Address for Notices to Selling Securityholder:

Telephone (including area code):

Fax (including area code):

Contact Person:

	(3)	 	Beneficial Ownership of Registrable Securities:

(a) Type and Principal Amount/Number of Registrable Securities beneficially owned:

(b) CUSIP No(s). of such Registrable Securities beneficially owned:

	(4)	 	Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder:

Except as set forth below in this Item (4), the Selling Securityholder is not the beneficial
or registered owner of any securities of the Company other than the Registrable Securities
listed above in Item (3).

(a) Type and Amount of Other Securities beneficially owned by the Selling Securityholder:

(b) CUSIP No(s). of such Other Securities beneficially owned:

	(5)	 	Relationship with the Company:

Except as set forth below, neither the Selling Securityholder nor any of its affiliates,
officers, directors or principal equity holders (5% or more) has held any position or office
or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.

State any exceptions here:

(6) Is the Selling Securityholder a registered broker-dealer?

Yes

No

If “Yes,” please answer subsection (a) and subsection (b):

(a)  Did the Selling Securityholder acquire the Registrable
Securities as compensation for underwriting/broker-dealer activities
to the Company?

Yes

No

(b)  If you answered “No” to question 6(a), please explain your
reason for acquiring the Registrable Securities:

(7) Is the Selling Securityholder an affiliate of a registered broker-dealer?

Yes

No

If “Yes,” please identify the registered broker-dealer(s), describe the nature of the
affiliation(s) and answer subsection (a) and subsection (b):

(a)  Did the Selling Securityholder purchase the Registrable
Securities in the ordinary course of business (if no, please
explain)?

Yes

No

Explain:

(b)  Did the Selling Securityholder have an agreement or
understanding, directly or indirectly, with any person to distribute
the Registrable Securities at the same time the Registrable
Securities were originally purchased (if yes, please explain)?

Yes

No

Explain:

(8) Is the Selling Securityholder a non-public entity?

Yes

No

If “Yes,” please answer subsection (a):

(a) Identify the natural person or persons that have voting or
investment control over the Registrable Securities that the
non-public entity owns:

(9) Plan of Distribution:

The Selling Securityholder (including its donees and pledgees) intends to distribute the
Registrable Securities listed above in Item (3) pursuant to the Registration Statement in
accordance with the Plan of Distribution attached as Annex A to the Registration Rights Agreement.

The Selling Securityholder acknowledges that it understands its obligations to comply with the
provisions of the Securities Exchange Act of 1934, as amended, and the rules thereunder relating to
stock manipulation, particularly Regulation M thereunder (or any successor rules or regulations),
in connection with any offering of Registrable Securities pursuant to the Shelf Registration
Agreement. The Selling Securityholder agrees that neither it nor any person acting on its behalf
will engage in any transaction in violation of such provisions.

Pursuant to the Registration Rights Agreement, the Company has agreed under certain
circumstances to indemnify the Selling Securityholder against certain liabilities.

In the event the Selling Securityholder transfers all or any portion of the Registrable
Securities listed in Item (3) above after the date on which such information is provided to the
Company other than pursuant to the Registration Statement, the Selling Securityholder agrees to
notify the transferee(s) at the time of the transfer of its rights and obligations under this
Selling Securityholder Questionnaire and the Registration Rights Agreement.

In accordance with the Selling Securityholder’s obligation under the Registration Rights
Agreement to provide such information as may be required by Law or by the staff of the Commission
for inclusion in the Registration Statement, the Selling Securityholder agrees to promptly notify
the Company of any inaccuracies or changes in the information provided herein that may occur
subsequent to the date hereof at anytime while the Registration Statement remains effective. All
notices to the Selling Securityholder pursuant to the Registration Rights Agreement shall be made
in writing, by hand-delivery, first-class mail, or air courier guaranteeing overnight delivery to
the address set forth below.

By signing below, the Selling Securityholder consents to the disclosure of the information
contained herein in its answers to Items (1) through (9) above and the inclusion of such
information in the Registration Statement and the related Prospectus. The undersigned understands
that such information will be relied upon by the Company in connection with the preparation or
amendment of the Registration Statement and the related Prospectus.

By signing below, the undersigned agrees that if the Company notifies the undersigned that the
Registration Statement is not available pursuant to the terms of the Registration Rights Agreement,
the undersigned will suspend use of the Prospectus until notice from the Company that the
Prospectus is again available.

Once this Selling Securityholder Questionnaire is executed by the undersigned and received by
the Company, the terms of this Selling Securityholder Questionnaire, and the representations,
warranties and agreements contained herein, shall be binding on, shall inure to the benefit of and
shall be enforceable by the respective successors, heirs, personal representatives, and assigns of
the Company and the undersigned with respect to the Registrable Securities beneficially owned by
the undersigned and listed in Item (3) above. This Selling Securityholder Questionnaire shall be
governed by and construed in accordance with the laws of the State of New York without regard to
choice of laws or conflicts of laws provisions thereof that would require the application of the
laws of any other jurisdiction.

8

IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Selling
Securityholder Questionnaire to be executed and delivered either in person or by its duly
authorized agent.

Dated:

Beneficial Owner

By:

Name:

Title:

PLEASE RETURN THE COMPLETED AND EXECUTED

SELLING SECURITYHOLDER QUESTIONNAIRE TO THE COMPANY AT:

CIFC Corp.

250 Park Avenue, 4th Floor

New York, NY 10177

Attention: Robert C. Milton III

Email: rmilton@cifc.com

9EX-10.2

Exhibit 10.2

SECOND AMENDED AND RESTATED

STOCKHOLDERS AGREEMENT

BY AND AMONG

CIFC CORP.,

DFR HOLDINGS, LLC

AND

CIFC PARENT HOLDINGS LLC

Dated as of September 24, 2012

1

2

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page
	Article I GENERAL
	 	 	2	 
	Section 1.1 Effective Date
	 	 	2	 
	Section 1.2 Definitions
	 	 	2	 
	Section 1.3 Construction
	 	 	10	 
	Section 1.4 Disclaimer of “Group” Status
	 	 	11	 
	Article II REPRESENTATIONS AND WARRANTIES
	 	 	11	 
	Section 2.1 Representations and Warranties of the Company
	 	 	11	 
	Section 2.2 Representations and Warranties of the Investors
	 	 	12	 
	Article III BOARD OF DIRECTORS
	 	 	13	 
	Section 3.1 Board of Directors
	 	 	13	 
	Section 3.2 Restrictions on Transfer
	 	 	16	 
	Section 3.3 Majority Voting Provision
	 	 	18	 
	Section 3.4 Controlled Company Exemption
	 	 	19	 
	Section 3.5 Covenants
	 	 	19	 
	Section 3.6 Committee Membership
	 	 	21	 
	Section 3.7 Board Observers
	 	 	22	 
	Section 3.8 Preemptive Rights
	 	 	22	 
	Section 3.9 Standstill
	 	 	23	 
	Article IV NON SOLICITATION
	 	 	25	 
	Section 4.1 Non Solicitation
	 	 	25	 
	Article V MISCELLANEOUS
	 	 	26	 
	Section 5.1 Termination of Agreement
	 	 	26	 
	Section 5.2 Expenses
	 	 	26	 
	Section 5.3 Notices
	 	 	26	 
	Section 5.4 Governing Law
	 	 	28	 
	Section 5.5 Consent to Jurisdiction
	 	 	28	 
	Section 5.6 Specific Performance
	 	 	29	 
	Section 5.7 Waiver of Jury Trial
	 	 	29	 
	Section 5.8 Binding Effect; Persons Benefiting; Assignment
	 	 	29	 
	Section 5.9 Counterparts
	 	 	29	 
	Section 5.10 Entire Agreement
	 	 	29	 
	Section 5.11 Severability
	 	 	29	 
	Section 5.12 Amendments and Waivers
	 	 	29	 
	Section 5.13 Delays or Omissions
	 	 	30	 
	Section 5.14 Mutual Drafting; Interpretation
	 	 	30	 

3

SECOND AMENDED AND RESTATED

STOCKHOLDERS AGREEMENT

THIS SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT, dated as of September 24, 2012 (this
“Agreement”), is by and among CIFC Corp., a Delaware corporation (formerly Deerfield
Capital Corp.) (the “Company”), DFR Holdings, LLC, a Delaware limited liability company
(“DFR Holdings”), and CIFC Parent Holdings LLC, a Delaware limited liability company
(“CIFC Parent,” and together with DFR Holdings, the “Investors” and, the Investors
together with the Company, the “Parties”).

WHEREAS, the Company is a party to the Asset Purchase Agreement, dated as of July 30, 2012
(the “Asset Purchase Agreement”), by and among the Company, CIFC Asset Management LLC, an
affiliate of the Company (“CIFCAM”), GE Capital Debt Advisors LLC (“GECDA”), and
General Electric Capital Corporation (“GECC”);

WHEREAS, as of the date hereof, DFR Holdings owns (a) 4,545,455 shares of common stock of the
Company, par value $0.001 per share (“Common Stock”), and (b) Senior Subordinated
Convertible Notes in the original principal amount of twenty-five million dollars ($25,000,000) and
due December 9, 2017 (the “Convertible Notes”), which are convertible into shares of Common
Stock (the “Conversion Shares”);

WHEREAS, as of the date hereof, CIFC Parent owns 9,090,909 shares of Common Stock;

WHEREAS, as conditions to the obligations of the Company, CIFCAM, GECC and GECDA to consummate
the Transactions (as defined in the Asset Purchase Agreement), (a) GE Capital Equity Investments,
Inc. (“GECEII”) and the Company intend to establish certain terms and conditions concerning
the corporate governance of the Company, the shares and warrants to purchase shares of the
Company’s capital stock held by GECEII and related provisions concerning the relationship of GECEII
with, and its investment in, the Company, as provided in the Investment Agreement dated as of the
date hereof (as amended and in effect, the “GE Investment Agreement”), and (b) the Company,
DFR Holdings, CIFC Parent and GECEII intend to enter into the Second Amended and Restated
Registration Rights Agreement dated as of the date hereof (the “Registration Rights
Agreement”);

WHEREAS, the Company and the Investors are parties to the Amended and Restated Stockholders
Agreement, dated as of April 13, 2011 (the “Original Agreement”);

WHEREAS, the execution and delivery of this Agreement is a condition to the obligations of the
GECC and GECDA to consummate the Transactions;

WHEREAS, pursuant to Section 5.12 of the Original Agreement, the Original Agreement may be
amended by a written instrument executed by each Investor and the Company and approved by a
majority of the Independent Directors (as defined in the Original Agreement) then serving on the
board of directors of the Company (the “Board”); and

WHEREAS, this Agreement was approved by a majority of the Independent Directors (as defined in
the Original Agreement) then serving on the Board at a meeting of the Board held on July 30, 2012.

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and
for other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Parties hereto agree as follows:

Article I

GENERAL

Section 1.1 Effective Date. This Agreement shall be delivered at the Closing and
shall not be effective, and the Parties shall not be bound by any obligations hereunder, until the
Closing occurs.

Section 1.2 Definitions. As used in this Agreement, the following terms shall have
the meanings indicated below:

“Acceptance Notice” has the meaning assigned in Section 3.2(b)(ii).

“Affiliate” means, with respect to any Person, any other Person, directly or
indirectly through one or more intermediaries, controlling, controlled by or under common control
with such Person; provided, that for purposes of this Agreement, the Company and its
Subsidiaries shall not be deemed to be Affiliates of any Investor and no Investor shall be deemed
to be an Affiliate of the Company and its Subsidiaries. The term “control” (including, with
correlative meaning, the terms “controlled by” and “under common control with”), as applied to any
Person, means the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of such Person, whether through the ownership of voting or other
securities, by contract or otherwise.

“Aggregate Cap Percentage” means eighty percent (80%).

“Agreement” has the meaning assigned in the preamble.

“Asset Purchase Agreement” has the meaning assigned in the recitals.

“Base Cap Percentage” means (i) in respect of the DFR Holdings Holders, 37.58%, and
(ii) in respect of the CIFC Holders, 39.28%.

“Beneficial Ownership” by a Person of any securities includes ownership by any Person
who, directly or indirectly, through any contract, arrangement, understanding, relationship or
otherwise, has or shares: (i) voting power which includes the power to vote, or to direct the
voting of, such security; and/or (ii) investment power which includes the power to dispose, or to
direct the disposition, of such security; and shall otherwise be interpreted in accordance with the
term “beneficial ownership” as defined in Rule 13d-3 adopted by the SEC under the Exchange Act;
provided, that for purposes of determining Beneficial Ownership, a Person shall be deemed
to be the Beneficial Owner of any securities that may be acquired by such Person pursuant to any
agreement, arrangement or understanding or upon the exercise of conversion rights, exchange rights,
warrants or options, or otherwise (irrespective of whether the right to acquire such securities is
exercisable immediately or only after the passage of time, including the passage of time in excess
of sixty (60) days, the satisfaction of any conditions, the occurrence of any event or any
combination of the foregoing). For purposes of this Agreement, (x) a Person shall be deemed to
Beneficially Own any securities Beneficially Owned by its Affiliates or any “group” (as
contemplated by Exchange Act Rule 13d-5(b)) of which such Person or any such Affiliate is or
becomes a member; provided, that, notwithstanding the foregoing, no Investor shall be
deemed to Beneficially Own the Investor Shares Beneficially Owned by any other Investor solely due
to the fact that the Investors constitute a group (as contemplated by Exchange Act Rule 13d-5(b)),
(y) for the avoidance of doubt, DFR Holdings shall be deemed to Beneficially Own the Conversion
Shares (assuming all Conversion Shares then issuable pursuant to the Convertible Notes Beneficially
Owned by the DFR Holdings Holders are outstanding), and (z) for the avoidance of doubt, neither
Investor or its Affiliates shall be deemed to Beneficially Own the GE Shares or the GE Warrant
Shares. The term “Beneficially Own” shall have a correlative meaning.

“Board” has the meaning assigned in the recitals.

“Buyer” has the meaning assigned in Section 3.2(a).

“Cap Percentage” means, in respect of any Investor, a percentage equal to such
Investor’s Base Cap Percentage; provided, however, that (i) an Investor’s Base Cap
Percentage shall be increased with respect to an acquisition by such Investor of Common Stock,
Convertible Notes or Other Capital Stock solely as a result of an Intra-Investor Private Transfer
(as hereafter defined) and (ii) to the extent that the sum of all Investors’ respective Base Cap
Percentages would exceed the Aggregate Cap Percentage as a result of an Intra-Investor Private
Transfer, the selling Investor’s Base Cap Percentage shall be decreased such that the sum of all
Investors’ respective Base Cap Percentages would equal the Aggregate Cap Percentage.
“Intra-Investor Private Transfer” means any Transfer by an Investor (or Affiliates thereof)
to one or more of the other Investors (or Affiliates of such other Investor) in a private
transaction, including a sale pursuant to the right of first refusal or right of first offer
contemplated by Section 3.2.

“CIFC CLO Issuer” means each of CIFC Funding 2006-I, Ltd. CIFC Funding 2006-IB, Ltd.,
CIFC Funding 2006-II, Ltd., CIFC Funding 2007-I, Ltd., CIFC Funding 2007-II, Ltd. CIFC Funding
2007-III, Ltd. and CIFC Funding 2007-IV, Ltd., and any co-issuer of any of the foregoing.

“CIFC CLO Management Agreements” means the collateral management agreements between
CIFC and the CIFC CLO Issuers in effect as of the Merger Agreement Closing.

“CIFC Holders” means, collectively, CIFC Parent and any Person that is both a
stockholder of the Company and an Affiliate of CIFC Parent and any successors thereto.

“CIFC Parent” has the meaning assigned in the preamble.

“CIFC Shares” means, as of the applicable measurement date, the sum of the shares of
Common Stock and Other Capital Stock Beneficially Owned by the CIFC Holders and any shares of
Common Stock or other securities issued in respect thereof or into which such shares of Common
Stock or other securities shall be converted in connection with stock splits, reverse stock splits,
stock dividends or distributions, combinations or any similar recapitalizations after the date of
this Agreement.

“CIFCAM” has the meaning assigned in the recitals.

“Closing” has the meaning ascribed to “Initial Closing” in the Asset Purchase
Agreement.

“CMA Requirement” means the requirement under each CIFC CLO Management Agreement, if
any, that for so long as CIFC is acting as the Collateral Manager (as defined in such CIFC CLO
Management Agreement), any one or more of the Collateral Manager, its Affiliates (as defined in
such CIFC CLO Management Agreement) and any employees of the Collateral Manager who are
Knowledgeable Employees (as defined in Rule 3c-5 of the Investment Company Act) with respect to the
applicable CIFC CLO Issuer shall collectively hold beneficial ownership directly or indirectly of
not less than a prescribed percentage or amount of, as applicable, the Preferred Shares (as
defined in such CIFC CLO Management Agreement) or Income Notes (as defined in such CIFC CLO
Management Agreement) issued and outstanding on the applicable closing date.

“CN CDO Issuer” means each of ColumbusNova CLO Ltd. 2006-I, ColumbusNova CLO Ltd.
2006-II, ColumbusNova CLO Ltd. 2007-I and ColumbusNova CLO Ltd. 2007-II.

“Common Stock” has the meaning assigned in the recitals.

“Company” has the meaning assigned in the preamble.

“Company CDO Issuer” means each DCM CDO Issuer and each CN CDO Issuer.

“Company CDO Issuer Documents” means each final or supplemental offering memorandum,
indenture and supplemental indenture, management agreement, trust agreement, collateral
administration agreement, insurance agreement, hedge agreement and swap agreement entered into, or
used in connection with an offering of securities, by a Company CDO Issuer.

“Company CDO Management Agreement” means the collateral management agreement between
the Company or applicable Subsidiary of the Company and each Company CDO Issuer.

“Company Client” means any Person whose assets, or the assets of whose clients, are
being managed by the Company or any of its Subsidiaries pursuant to an investment advisory or
similar agreement.

“Company Investor” means any Person or entity that is an investor, lender or wrapper
in any investments or investment products (including any collateralized debt obligations,
collateralized loan obligations, funds and any separately managed accounts), whether now or
hereafter existing, that are managed by the Company or any of its Subsidiaries.

“Consents” means all consents, notices, authorizations, novations, Orders, waivers,
approvals, licenses, accreditations, certificates, declarations, filings or expiration of waiting
periods, non-objection or confirmation by a rating agency that an action or event will not result
in the reduction or withdrawal of a rating.

“Constituent Documents” means, with respect to any Person that is a corporation, its
articles or certificate of incorporation (for the avoidance of doubt, including any certificates of
designation with respect to capital stock of such Person), corporate charter or memorandum and
articles of association, as the case may be, and bylaws, with respect to any Person that is a
partnership, its certificate of partnership and partnership agreement, with respect to any Person
that is a limited liability company, its certificate of formation and limited liability company or
operating agreement, with respect to any Person that is a trust or other entity, its declaration or
agreement of trust or other constituent document, and with respect to any other Person, its
comparable organizational documents, in each case, as amended or restated.

“Contract” means any written or oral contract, agreement, lease, license, indenture,
note, bond, mortgage, loan, instrument, conditional sale contract, guarantee commitment or other
arrangement, understanding, undertaking or obligation.

“Conversion Shares” has the meaning assigned in the recitals.

“Convertible Notes” has the meaning assigned in the recitals.

“Cure Period” has the meaning assigned in Section 3.1(d)(iii).

“Cure Purchase” has the meaning assigned in Section 3.1(d)(iii).

“CypressTree CLO Issuer” means each of Primus CLO I, Ltd., Primus CLO II, Ltd.,
Hewett’s Island CLO I-R, Ltd., Hewett’s Island CLO II, Ltd., Hewett’s Island CLO III, Ltd.,
Hewett’s Island CLO V, Ltd., Hewett’s Island CLO VI, Ltd., WhiteBark Pine I, Ltd. and
CypressTree Synthetic CDO Limited, and any co-issuer of any of the foregoing.

“DCM CDO Issuer” means each of Bridgeport CLO Ltd., Bridgeport CLO II Ltd., Buckingham
CDO Ltd., Buckingham CDO II Ltd., Buckingham CDO III Ltd., Burr Ridge CLO Plus Ltd., DFR Middle
Market CLO Ltd., Cumberland II CLO Ltd., Forest Creek CLO Ltd., Gillespie CLO PLC, Knollwood CDO
Ltd., Knollwood CDO II Ltd., Long Grove CLO Ltd., Market Square CLO Ltd., Marquette Park CLO Ltd.,
Mid Ocean CBO 2000-1 Ltd., Mid Ocean CBO 2001-1 Ltd., NorthLake CDO I, Limited, Pinetree CDO Ltd.,
River North CDO Ltd., Rosemont CLO, Ltd., Schiller Park CLO Ltd., Valeo Investment Grade CDO Ltd.,
Valeo Investment Grade CDO II Ltd., Robeco CDO II Limited and Mayfair Euro CDO I B.V.

“Denominator Shares” means, as of the applicable measurement date, together, the sum
of (i) the outstanding shares of Common Stock and any Other Capital Stock, (ii) the Conversion
Shares issuable upon the conversion of the aggregate amount Convertible Notes then outstanding
(calculated assuming all Conversion Shares then issuable pursuant to the Convertible Notes are
outstanding), (iii) any issued GE Warrant Shares, and (iv) Warrant Shares issuable to the Initial
Holder (as defined in the GE Warrant) upon exercise of the GE Warrant.

“DFR Holdings” has the meaning assigned in the preamble.

“DFR Holdings Holders” means, collectively, DFR Holdings and any Person that is both a
stockholder of the Company and an Affiliate of DFR Holdings and any successors thereto.

“DFR Holdings Shares” means, as of the applicable measurement date, the sum of the
shares of Common Stock and Other Capital Stock Beneficially Owned by the DFR Holdings Holders
(including, for the avoidance of doubt, the Conversion Shares assuming all Conversion Shares then
issuable pursuant to the Convertible Notes Beneficially Owned by the DFR Holdings Holders are
outstanding) and any shares of Common Stock or other securities issued in respect thereof or into
which such shares of Common Stock or other securities shall be converted in connection with stock
splits, reverse stock splits, stock dividends or distributions, combinations or any similar
recapitalizations after the date of this Agreement.

“Dilution Notice” has the meaning assigned in Section 3.1(d)(iii).

“Director” means any member of the Board.

“Equity Interest” means any type of equity ownership in an entity, including
partnership interests in a general partnership or limited partnership, membership interests in a
limited liability company, stock or similar security in a corporation or the comparable instruments
for any other entity or any other interest entitling the holder thereof to participate in the
profits of such entity, the proceeds or the disposition of such entity or any portion thereof or to
vote for the governing body of such entity.

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules
and regulations promulgated thereunder.

“GE Holder” has the meaning ascribed to “Investor Holder” in the GE Investment
Agreement.

“GE Investment Agreement” has the meaning assigned in the recitals.

“GE Shares” means, as of the applicable measurement date, the sum of the shares of
Common Stock and Other Capital Stock Beneficially Owned by the GE Holders and any shares of Common
Stock or other securities issued in respect thereof or into which such shares of Common Stock or
other securities shall be converted in connection with stock splits, reverse stock splits, stock
dividends or distributions, combinations or any similar recapitalizations after the date of this
Agreement

“GE Warrant” has the meaning ascribed to “Investor Warrant” in the GE Investment
Agreement.

“GE Warrant Shares” has the meaning ascribed to “Warrant Shares” in the GE Investment
Agreement.

“GECC” has the meaning assigned in the recitals.

“GECDA” has the meaning assigned in the recitals.

“GECEII” has the meaning assigned in the recitals.

“Governmental Approvals” means all Consents of a Governmental Authority required in
connection with the transactions contemplated hereby.

“Governmental Authority” means any foreign, federal, state or local governmental,
judicial, legislative, regulatory or administrative agency, commission or authority, and any court,
tribunal or arbitrator(s) of competent jurisdiction, including Self-Regulatory Organizations.

“Independent Director” means a Director who qualifies as an “independent director” of
the Company under (a) the Corporate Governance Guidelines of the Company then in effect and
(b)(i) applicable NASDAQ rules, as such rules may be amended, supplemented or replaced from time to
time, or (ii) if the Common Stock is listed on a securities exchange or quotation system other than
NASDAQ, any comparable rule or regulation of the primary securities exchange or quotation system on
which the Common Stock is listed or quoted (whether by final rule or otherwise); provided,
that, notwithstanding anything herein to the contrary, a Director shall not be an “Independent
Director” if such Director would not be independent of each Investor under applicable state
corporate law. The fact that an individual has been designated by any Investor for nomination
pursuant to this Agreement will not, in and of itself, disqualify that individual as an Independent
Director

“Investor” has the meaning assigned in the preamble.

“Investor Shares” means collectively, the DFR Holdings Shares and the CIFC Shares.

“Law” means any statute, code, Order, law, ordinance, rule, regulation or other
requirement of any Governmental Authority (including, for the sake of clarity, common law).

“Lien” means any lien, pledge, encumbrance, mortgage, deed of trust, security
interest, equity, claim, lease, license, charge, option, adverse right, right of first or last
negotiation, offer or refusal, easement or transfer restriction of any kind or nature whatsoever,
whether arising by agreement, operation of Law or otherwise.

“Management Agreements” means (i) the Management Agreement by and between the Company
and CIFC Parent dated as of the date hereof and (ii) the Management Agreement by and between the
Company and Bounty dated as of the date hereof.

“Merger Agreement Closing” has the meaning ascribed to “Closing” in the Agreement and
Plan of Merger, dated as of December 21, 2010, as amended, by and among the Company, Bulls I
Acquisition Corporation, Bulls II Acquisition LLC, CIFC Parent and Commercial Industrial Finance
Corp.

“NASDAQ” means the NASDAQ Stock Market LLC.

“Necessary Action” means, with respect to a specified result, all reasonable actions
(to the extent not prohibited by Law) necessary to cause such result, including (i) voting or
providing a written consent or proxy with respect to the Investor Shares, (ii) causing the adoption
of stockholders’ resolutions and amendments to the Constituent Documents of the Company,
(iii) refraining from objecting and waiving any available statutory appraisal or similar rights,
(iv) executing agreements and instruments, (v) obtaining, or causing to be obtained, all
Governmental Approvals and Third Party Consents, (vi) nominating or electing any members of the
Board, (vii) removing any members of the Board whom the person obliged to take the Necessary Action
has the right to remove, and (viii) calling or causing to be called a special meeting of the Board
or stockholders of the Company.

“New Shares” means any Equity Interests of the Company or any of its Subsidiaries,
including Common Stock or Other Capital Stock, whether authorized or not by the Board or any
committee of the Board, and rights, options, or warrants to purchase any Equity Interest, and
securities of any type whatsoever that are, or may become, convertible into any Equity Interest;
provided, however, that the term “New Shares” shall not include: (i) securities
issued to employees, consultants, officers and directors of the Company, pursuant to any
arrangement approved by the Board or the Board’s compensation committee; (ii) securities issued as
consideration in the acquisition of another business or assets of another Person by the Company by
merger or purchase of the assets or shares, reorganization or otherwise; (iii) securities issued
pursuant to any rights or agreements, including, without limitation, convertible securities,
options and warrants, provided, that either (x) the Company shall have complied with
Section 3.8 with respect to the initial sale or grant by the Company of such rights or
agreements or (y) such rights or agreements existed prior to the Merger Agreement Closing (it being
understood that any modification or amendment to any such pre-existing right or agreement
subsequent to the Merger Agreement Closing with the effect of increasing the percentage of the
Company’s fully-diluted securities underlying such rights agreement shall not be included in this
clause (iii)); (iv) securities issued in connection with any stock split, stock dividend,
recapitalization, reclassification or similar event by the Company; (v) Conversion Shares issued
upon conversion of any portion of the then outstanding Convertible Notes; (vi) warrants issued to
the lender in a bona fide debt financing; (vii) securities registered under the Securities Act that
are issued in an underwritten public offering; (viii) any right, option, or warrant to acquire any
security convertible into the securities excluded from the definition of New Shares pursuant to
clauses (i) through (vii) above; (ix) any issuance by a Subsidiary of the Company to the Company or
a wholly-owned Subsidiary of the Company; (x) GE Warrant Shares issued upon exercise of any portion
of the GE Warrant; and (xi) any issuance as to which the Requisite Investors elect to waive the
rights set forth in Section 3.8.

“New Shares Notice” has the meaning assigned in Section 3.8(b).

“Nominating Committee” means the Nominating and Corporate Governance Committee of the
Board.

“Note Offer” has the meaning assigned in Section 3.2(a).

“Offer Notice” has the meaning assigned in Section 3.2(b)(i).

“Offered Shares” has the meaning assigned in Section 3.2(b).

“Offeree Investor” has the meaning assigned in Section 3.2(b).

“Option Period” has the meaning assigned in Section 3.2(b)(ii).

“Order” means any judgment, order, injunction, stipulation, decree, writ, doctrine,
ruling, assessment or arbitration award or similar order of any Governmental Authority.

“Original Agreement” has the meaning assigned in the recitals.

“Other Capital Stock” means shares of any class of capital stock of the Company (other
than the Common Stock) that are entitled to vote generally in the election of Directors.

“Outstanding Stock” means, as of the applicable measurement date, together, the sum of
(i) the outstanding shares of Common Stock and any Other Capital Stock and (ii) the Conversion
Shares issuable upon the conversion of the aggregate amount Convertible Notes then outstanding
(calculated assuming all Conversion Shares then issuable pursuant to the Convertible Notes are
outstanding).

“Parties” has the meaning assigned in the recitals.

“Person” means any individual, corporation, partnership, limited liability company,
limited liability partnership, firm, joint venture, association, joint-stock company, trust,
unincorporated organization, Governmental Authority or other entity.

“Pro Rata Portion” has the meaning assigned in Section 3.8(a).

“Preemptive Right” has the meaning assigned in Section 3.8(a).

“Registration Rights Agreement” has the meaning assigned in the recitals.

“Requisite Investors” shall mean each Investor that Beneficially Owns Investor Shares
representing at least twenty percent (20%) of the Outstanding Stock.

“ROFR Acceptance Notice” has the meaning assigned in Section 3.2(a)(ii).

“ROFR Investor” has the meaning assigned in Section 3.2(a)(i).

“ROFR Notes” has the meaning assigned in Section 3.2(a)(i).

“ROFR Notice” has the meaning assigned in Section 3.2(a)(i).

“ROFR Period” has the meaning assigned in Section 3.2(a)(ii).

“SEC” means the United States Securities and Exchange Commission or any successor
entity thereto.

“Self-Regulatory Organization” means each national securities exchange in the United
States of America or other commission, board, agency or body that is charged with the supervision
or regulation of brokers, dealers, securities underwriting or trading, stock exchanges, commodities
exchanges, insurance companies or agents, investment companies or investment advisers, or to the
jurisdiction of which any Party or any of their respective Subsidiaries is otherwise subject.

“Subsidiary” means, with respect to any Person, a corporation or other Person of which
more than fifty percent (50%) of the voting power of the outstanding voting Equity Interests or
more than fifty percent (50%) of the outstanding economic Equity Interest is held, directly or
indirectly, by such Person.

“Tail Period” has the meaning assigned in Section 4.1.

“Termination Notice” has the meaning assigned in Section 5.1(a)(ii).

“Third Party” means any Person other than the Company, its Subsidiaries and the
Investors and each of such Person’s respective members, directors, officers and Affiliates.

“Third Party Consents” means all consents or waivers or notices to any party (other
than a Governmental Authority) to any Contract to which any of the Parties hereto is a party or by
which any of their respective assets or properties are bound.

“Trading Day” means any day on which the Common Stock is traded on NASDAQ, or, if
NASDAQ is not the principal trading market for the Common Stock, then on the principal securities
exchange or securities market on which the Common Stock is then traded.

“Transactions” has the meaning assigned in the preamble.

“Transfer” means the transfer of ownership by sale, exchange, assignment, pledge,
encumbrance, lien, gift, donation, grant or other conveyance of any kind, whether voluntary or
involuntary, including conveyances by operation of Law or legal process (and hereby expressly
includes, with respect to an Investor, any voluntary or involuntary appointment of a receiver,
trustee, liquidator, custodian or other similar official for such Investor or all or any part of
such Investor’s property under any bankruptcy Law). For the avoidance of doubt, the Parties hereto
acknowledge and agree that any Transfer of the Equity Interests of any Investor or any Affiliate of
such Investor that controls such Investor will be deemed a Transfer of the Investor Shares held by
such Investor under this Agreement if, following such Transfer such Investor is no longer
controlled, directly or indirectly, by the Person or Persons that control, directly or indirectly,
such Investor on the date hereof or by an Affiliate or Affiliates thereof; provided,
however, that a Transfer of limited partnership interests in an investment fund that
controls, directly or indirectly, such Investor shall not be deemed a Transfer of such Investor’s
Shares hereunder so long as the manager, advisor or general partner (or Person acting in a similar
capacity) that controls such investment fund on the date hereof or an Affiliate thereof continues
to control such investment fund following such Transfer.

“Transferring Investor” has the meaning assigned in Section 3.2(b).

“Transferring Noteholder” has the meaning assigned in Section 3.2(a).

Section 1.3 Construction. Unless the context of this Agreement clearly requires
otherwise: (i) references to the plural include the singular and vice versa; (ii) references to one
gender include all genders; (iii) whenever the words “include,” “includes” or “including” are used
in this Agreement they will be deemed to be followed by the phrase “without limitation;” (iv) the
words “hereof,” “herein,” “hereby,” “hereunder” and similar terms in this Agreement refer to this
Agreement as a whole and not to any particular provision of this Agreement; (v) when a reference is
made in this Agreement to a Section, Schedule, Exhibit or Annex, such reference shall be to a
Section, Schedule, Exhibit or Annex of this Agreement unless otherwise indicated; (vi) all
references in this Agreement to “$” are intended to refer to U.S. dollars; (vii) unless otherwise
specifically provided for herein, the term “or” shall not be deemed to be exclusive; and (viii) any
reference to Law shall include any amendment thereof or any successor thereto and any rules and
regulations promulgated thereunder. The table of contents and headings contained in this Agreement
are for reference purposes only and shall not affect in any way the meaning or interpretation of
this Agreement.

Section 1.4 Disclaimer of “Group” Status. Each Investor hereby expressly disclaims
Beneficial Ownership of any Equity Interests in the Company held by GECEII and its Affiliates.
This Agreement shall not constitute a written or oral agreement by either Investor or any Affiliate
of such Investor to act together with GECEII or any of its Affiliates for the purpose of acquiring,
holding, voting or disposing of any Equity Interests in the Company. 

Article II

REPRESENTATIONS AND WARRANTIES

Section 2.1 Representations and Warranties of the Company. The Company represents and
warrants to each Investor as of the date hereof that:

(a) The Company is duly incorporated, validly existing and in good standing under the Laws of
Delaware with all requisite power and authority required to conduct its business as presently
conducted.

(b) The Company has all requisite corporate power and authority to execute and deliver this
Agreement and to perform its obligations hereunder. The execution and delivery by the Company of
this Agreement and the performance by the Company of its obligations hereunder have been duly
authorized by all requisite corporate action of the Company. No other action on the part of the
Company is necessary to authorize the execution, delivery and performance by the Company of this
Agreement.

(c) This Agreement has been duly executed and delivered by the Company and, assuming this
Agreement has been duly authorized, executed and delivered by each of the Investors, constitutes
the legal, valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms, except to the extent that the enforceability thereof may be limited by:
(i) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar
Laws from time to time in effect affecting generally the enforcement of creditors’ rights and
remedies and (ii) general principles of equity, regardless of whether enforcement is sought in
equity or at Law.

(d) Other than any filings required by the Exchange Act (which the Company shall file with the
SEC when and as the same is due), the execution and delivery of this Agreement and the performance
by the Company of its obligations under this Agreement: (i) does not violate any provision of the
Constituent Documents of the Company; and (ii)(A) does not conflict with or violate any applicable
Law of any Governmental Authority having jurisdiction over the Company or any part of the
properties or assets of the Company, (B) does not require the Consent of any Person under, violate,
result in the termination or acceleration of or of any right under, give rise to or modify any
right or obligation under (whether or not in combination with any other event or circumstance), or
conflict with, breach or constitute a default under (in each case with or without notice, the
passage of time or both), any Contract to which the Company is a party or by which any of its
properties or assets is bound, (C) does not result in the creation or imposition of any Lien on any
part of the properties or assets of the Company, (D) does not violate any Order binding on the
Company or any part of its properties or assets, and (E) does not otherwise require any
Governmental Approvals or any Third Party Consents.

Section 2.2 Representations and Warranties of the Investors. Each Investor represents
and warrants to the Company on behalf of itself and not jointly that as of the date hereof:

(a) Such Investor is duly formed, validly existing and in good standing under the Laws of
Delaware with all requisite power and authority required to conduct its business as presently
conducted.

(b) Such Investor has all requisite limited liability power and authority to execute and
deliver this Agreement and to perform its obligations hereunder. The execution and delivery by
such Investor of this Agreement and the performance by such Investor of its obligations hereunder
have been duly authorized by all requisite limited liability company action of such Investor. No
other action on the part of such Investor or its members is necessary to authorize the execution,
delivery and performance by such Investor of this Agreement.

(c) This Agreement has been duly executed and delivered by such Investor and, assuming this
Agreement has been duly authorized, executed and delivered by the Company, constitutes the legal,
valid and binding obligation of such Investor, enforceable against such Investor in accordance with
its terms, except to the extent that the enforceability thereof may be limited by: (i) applicable
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar Laws from time
to time in effect affecting generally the enforcement of creditors’ rights and remedies; and (ii)
general principles of equity regardless of whether enforcement is sought in equity or at Law.

(d) Other than the filings required by Section 13 of the Exchange Act (which such Investor
shall file with the SEC when and as the same is due), the execution and delivery of this Agreement
by such Investor and the performance by such Investor of its obligations under this Agreement: (i)
does not violate any provision of the Constituent Documents of such Investor; and (ii)(A) does not
conflict with or violate any applicable Law of any Governmental Authority having jurisdiction over
the Investor or any part of the properties or assets of the Investor, (B) does not require the
Consent of any Person under, violate, result in the termination or acceleration of or of any right
under, give rise to or modify any right or obligation under (whether or not in combination with any
other event or circumstance), or conflict with, breach or constitute a default under (in each case
with or without notice, the passage of time or both), any Contract to which such Investor is a
party or by which any of its properties or assets is bound, (C) does not result in the creation or
imposition of any Lien on any part of the properties or assets of such Investor, (D) does not
violate any Order binding on such Investor or any part of its properties or assets, and (E) does
not otherwise require any Governmental Approvals or any Third Party Consents.

Article III

BOARD OF DIRECTORS

Section 3.1 Board of Directors.

(a) Size of the Board. The Board shall consist of eleven (11) Directors. Each
Investor agrees to take, or cause to be taken, all other Necessary Action, to ensure that (x) the
number of Directors constituting the Board shall be set and remain at eleven (11) Directors and
(y) each directorship shall be subject to reelection at each annual meeting of the Company’s
Stockholders (i.e., the Board will not be “classified” or “staggered”).

(b) Board Composition. Subject to Section 3.1(d) and Section 3.1(k)
below, (1) the Board shall nominate or cause to be nominated, and shall recommend for election,
individuals to serve as Directors in accordance with the designations in this Section
3.1(b) and (2) each Investor agrees to take, or cause to be taken, all Necessary Action, to
ensure that at each annual or special meeting of stockholders at which an election of Directors is
held or pursuant to any written consent of the stockholders, in each case that includes as a matter
to be acted upon by the stockholders the election of directors (including, without limitation, the
filling of a vacancy existing on the Board), such persons shall be elected to the Board:

(i) three (3) Directors designated by DFR Holdings (initially such Directors shall be Andrew
Intrater, Jason Epstein and Paul Lipari);

(ii) three (3) Directors designated by CIFC Parent (initially such Directors shall be Michael
R. Eisenson, Samuel P. Bartlett and Tim R. Palmer);

(iii) the Company’s then serving Chief Executive Officer, who shall initially be Peter
Gleysteen (the “CEO Director”);

(iv) three (3) Independent Directors designated by the Nominating Committee; provided,
that the initial Independent Directors shall be Frederick Arnold, Robert B. Machinist and Frank C.
Puleo; and

(v) one (1) Director designated by the Nominating Committee.

(c) Removal; Vacancy.

(i) Except as provided in Section 3.1(d) or as required by applicable Law, no Director
designated pursuant to Section 3.1(b) above may be removed from office unless (A) in the
case of a Director designated by DFR Holdings pursuant to Section 3.1(b)(i), such removal
is directed or approved by DFR Holdings, (B) in the case of a Director designated by CIFC Parent
pursuant to Section 3.1(b)(ii), such removal is directed or approved by CIFC Parent, (C) in
the case of a Director designated pursuant to Section 3.1(b)(iv) or Section
3.1(b)(v), such removal is directed or approved by the Nominating Committee, (D) in the case of
the CEO Director, pursuant to Section 3.1(c)(iii). Each Investor shall vote its Investor
Shares and take, or shall cause to be taken, all other Necessary Action to effect any removal
contemplated by this Section 3.1(c), subject, in the case of a removal pursuant to clause
(C) of this Section 3.1(c)(i), to the prior approval of the Nominating Committee.

(ii) Except as provided in Section 3.1(d), (A) upon the death, disability, retirement,
resignation or other removal of a Director designated by DFR Holdings pursuant to Section
3.1(b)(i) above, the Board shall appoint as a Director to fill the vacancy so created an
individual designated by DFR Holdings, (B) upon the death, disability, retirement, resignation or
other removal of a Director designated by CIFC Parent pursuant to Section 3.1(b)(ii) above,
the Board shall appoint as a Director to fill the vacancy so created an individual designated by
CIFC Parent, and (C) upon the death, disability, retirement, resignation or other removal of a
Director designated by the Nominating Committee pursuant to Section 3.1(b)(iv) or
Section 3.1(b)(v), the Board shall appoint as a Director to fill the vacancy so created an
individual designated by the Nominating Committee.

(iii) If for any reason the CEO Director shall cease to serve as the Chief Executive Officer
of the Company, the Company shall seek to obtain the immediate resignation of the CEO Director as a
Director of the Company contemporaneously with such CEO Director’s termination of service to the
Company as its Chief Executive Officer. In the event such resignation is not effective within ten
(10) days of such termination of service, upon the written request of any Investor, the Company
shall call a special meeting of stockholders or seek the written consents of stockholders, in each
case to approve or consent to the removal of the CEO Director (to the extent permitted by Law and
the Company’s Constituent Documents). In connection with any such meeting or written consent, each
of the Investors shall vote their respective Investor Shares (A) to remove the former Chief
Executive Officer from the Board if such individual has not previously resigned as a Director (to
the extent permitted by Law and the Company’s Constituent Documents) and (B) to elect such person’s
replacement as Chief Executive Officer of the Company (if any) as the new CEO Director. Any
employment agreement between the Company and the Chief Executive Officer of the Company shall
contain a requirement that the Chief Executive Officer of the Company resign as the CEO Director
contemporaneous with termination of his service as the Chief Executive Officer of the Company.
Notwithstanding anything to the contrary in the foregoing, an individual who formerly served as the
CEO Director and/or Chief Executive Officer of the Company may be nominated, designated, and/or
elected as a Director of the Company (other than the CEO Director) in accordance with Section
3.1(b) above.

(d) Loss of Investor’s Right to Designate Director.

(i) If the Investor Shares Beneficially Owned by any Investor represent less than twenty-five
percent (25%) but at least fifteen percent (15%) of the Outstanding Stock, the number of Directors
that such Investor shall be entitled to designate pursuant to Section 3.1(b)(i) or
Section 3.1(b)(ii) (as applicable) shall be reduced to two (2). If the Investor Shares
Beneficially Owned by any Investor represent less than fifteen percent (15%) but at least five
percent (5%) of the Outstanding Stock, the number of Directors that such Investor shall be entitled
to designate pursuant to Section 3.1(b)(i) or Section 3.1(b)(ii) (as applicable)
shall be reduced to one (1). For the avoidance of doubt, (A) if any Investor ceases to
Beneficially Own Investor Shares representing at least five percent (5%) of the Outstanding Stock,
such Investor shall not be entitled to designate any Director pursuant to Section 3.1(b)(i)
or Section 3.1(b)(ii) and (B) except as provided in Section 3.1(d)(iii) below, once
any Investor loses its right to designate any Director pursuant to this Section 3.1(d)(i),
such Investor shall not be entitled to regain its right to designate such Director, even if such
Investor subsequently Beneficially Owns a number of Investor Shares in excess of the applicable
threshold.

(ii) To the extent that an Investor ceases to have the right to designate a Director pursuant
to Section 3.1(d)(i), if requested by a majority of the Directors then serving on the Board
(other than any Director designated by such Investor), such Investor shall promptly take all
Necessary Action to cause the resignation of that number of Investor-designated Directors as is
required to cause the remaining number of Investor-designated Directors to conform to Section
3.1(d)(i); provided, that such Investor shall not be required to cause any
Investor-designated Director(s) to resign in accordance with this Section 3.1(d)(ii) as a
result of a dilution of the Investor Shares (other than dilution resulting from the issuance of New
Shares) unless and until the Company complies with procedures in Section 3.1(d)(iii) below.
Promptly following any such resignation in accordance with this Section 3.1(d)(ii), (A) if
immediately following such resignation the number of Directors serving on the Board is eight (8) or
more, the Investors shall take, or cause to be taken, all Necessary Action to reduce the size of
the Board by the number of Directors who have so resigned, and (B) if immediately following such
resignation the number of Directors serving on the Board is less than eight (8), if and only if
requested by a majority of the Independent Directors then serving on the Board, the Investors shall
take, or cause to be taken, all Necessary Action to reduce the size of the Board by the number of
Directors who have so resigned.

(iii) Notwithstanding anything in Section 3.1(d)(i) or Section 3.1(d)(ii) to
the contrary, if the Investor Shares Beneficially Owned by any Investor represent a percentage of
Outstanding Stock that is less than the applicable minimum percentage specified in Section
3.1(d)(i) as a result of dilution of the Investor Shares, other than dilution resulting from
the issuance of New Shares, the Company shall deliver a written notice to the Investors of such
dilution event (the “Dilution Notice”). If (A) within twenty (20) days following receipt
of the Dilution Notice, such Investor gives the Company a written notice of its intention to
acquire, directly or indirectly through its Affiliates, an amount of Common Stock, Other Capital
Stock or, in the case of the DFR Holdings Holders, Convertible Notes, such that immediately
following such acquisition such Investor’s Investor Shares represent a percentage of Outstanding
Stock equal to the applicable minimum percentage of Outstanding Stock specified in Section
3.1(d)(i), as applicable (a “Cure Purchase”) within ninety (90) days of the Company’s
receipt of the Dilution Notice (the “Cure Period”) and (B) the Cure Purchase is consummated
during the Cure Period, then such Investor shall not be required to cause any Director(s)
designated by such Investor to resign in accordance with Section 3.1(d)(ii).

(e) Eligible Investor Shares. For the purpose of determining the number of Directors
each Investor shall be entitled to designate for nomination pursuant to this Section 3.1 at
a stockholder meeting, the Investor Shares Beneficially Owned by such Investor shall be calculated
as of the close of business on the last Trading Day of the month immediately prior to the date on
which the Nominating Committee designates the Independent Director nominees for election at the
relevant stockholder meeting.

(f) Company Solicitation. The Company shall cause each individual designated in
accordance with Section 3.1(b) to be included in the Board’s “slate” of nominees for the
applicable meeting of stockholders and shall use commercially reasonable best efforts to solicit
from its stockholders eligible to vote for the election of Directors proxies (i) in favor of the
election of such individuals and (ii) against removal of each such individual (to the extent such
individual is serving as a Director).

(g) Compensation and Benefits. The compensation and benefits of all Directors shall
be determined with the approval of a majority of the Board and a majority of Independent Directors.

(h) Indemnification. Notwithstanding anything to the contrary in Section
3.1(g), the Company shall to the maximum extent permitted under applicable Law, indemnify and
provide for the advancement of expenses to each Director designated by the Investors, from and
against any and all losses which may be imposed on, incurred by, or asserted against such Director
in any way relating to or arising out of, or alleged to relate to or arise out of, the Director’s
service in that capacity pursuant to the Company’s Constituent Documents and an indemnification
agreement in the form heretofore provided to the Investors.

(i) Insurance. The Directors designated by the Investors shall be covered by the
directors’ and officers’ liability insurance and fiduciary liability insurance carried by the
Company in an amount reasonably acceptable to the Investors.

(j) No Liability for Election of Recommended Directors. No Investor, nor any
Affiliate of any Investor, shall have any liability as a result of designating an individual for
election as a Director for any act or omission by such designated individual in his or her capacity
as a Director of the Company, nor shall any Investor have any liability as a result of voting for
any such designee in accordance with the provisions of this Agreement.

(k) Designating Directors. Any Person designated as a Director pursuant to
Section 3.1(b) by DFR Holdings, CIFC Parent or the Nominating Committee shall be subject to
satisfaction of the requirements of applicable Law and corporate governance policies adopted by the
Board.

Section 3.2 Restrictions on Transfer.

(a) In the event that any Investor entertains a bona fide offer to purchase all or any portion
of the Convertible Notes held by such Investor (a “Note Offer”) from any Third Party (a
“Buyer”), such Investor (a “Transferring Noteholder”) may Transfer such Convertible
Notes only pursuant to and in accordance with the following provisions of this Section
3.2(a).

(i) The Transferring Noteholder shall cause the Note Offer and all of the terms thereof to be
reduced to writing and shall promptly notify the other Investor (the “ROFR Investor”) of
such Transferring Noteholder’s desire to effect the Note Offer and otherwise comply with the
provisions of this Section 3.2(a) (such notice, the “ROFR Notice”). The
Transferring Noteholder’s ROFR Notice shall constitute an irrevocable offer to sell all but not
less than all of the Convertible Notes that are the subject of the Note Offer (the “ROFR
Notes”) to the ROFR Investor at a purchase price equal to the price contemplated by, and on the
same terms and conditions of, the Note Offer. The ROFR Notice shall be accompanied by a true copy
of the Note Offer (which shall identify the Buyer and all relevant information in connection
therewith).

(ii) At any time within fifteen (15) days after receipt by the ROFR Investor of the ROFR
Notice (the “ROFR Period”), the ROFR Investor (or any of its Affiliates) may elect to
accept the offer to purchase with respect to all but not less than all of the ROFR Notes and shall
give written notice of such election (the “ROFR Acceptance Notice”) to the Transferring
Noteholder within the ROFR Period. The ROFR Acceptance Notice shall constitute a valid, legally
binding and enforceable agreement for the sale and purchase of the ROFR Notes.

(iii) In the event that the ROFR Investor does not elect (together with its Affiliates) to
purchase all of the ROFR Notes pursuant to Section 3.2(a)(ii), during the sixty (60)-day
period following the expiration of the ROFR Period the Transferring Noteholder may sell all of the
ROFR Notes to the Buyer on the terms and conditions set forth in the Note Offer; provided,
that, as a condition to the consummation of such Transfer, the Buyer executes and delivers to the
Company and each Investor (other than the Investor effecting such Transfer) an agreement assuming
the obligations of an Investor set forth in this Agreement in form and substance reasonably
satisfactory to the Company and each such Investor. If the Transferring Noteholder does not
consummate the Transfer of the ROFR Notes to the Buyer in accordance with this Section
3.2(a)(iii) within such sixty (60)-day period, then the Note Offer shall be deemed to lapse and
any Transfer pursuant to such Note Offer shall be in violation of the provisions of this
Section 3.2(a) unless the Transferring Noteholder sends a new ROFR Notice and once again
complies with the provisions of this Section 3.2(a) with respect to such Note Offer.

(b) In the event that any Investor proposes to Transfer, in one or more transactions, all or
any portion of such Investor’s Investor Shares (excluding the Convertible Notes), such Investor
(the “Transferring Investor”) shall first offer such Investor Shares (the “Offered
Shares”) to the other Investor (the “Offeree Investor”) in accordance with this
Section 3.2(b); provided, that in no event shall a Transferring Investor be
required to offer the Offered Shares to the Offeree Investor if such Offered Shares (together with
all other Investor Shares Transferred by such Investor in the preceding twelve (12)-month period)
constitute less than the lesser of (x) 4.99% of the Outstanding Stock and (y) ten percent (10%) of
the Investor Shares held by such Investor immediately prior to any such Transfer.

(i) The Transferring Investor shall provide written notice to the other Investor of such
Transferring Investor’s desire to Transfer the Offered Shares, specifying in reasonable detail the
terms and conditions as to such Transfer (including, without limitation, the number of Offered
Shares and the purchase price therefor) (such notice, the “Offer Notice”). The Offer
Notice shall constitute an irrevocable offer to sell all but not less than all of the Offered
Shares to the other Investor on the terms and conditions set forth in the Offer Notice.

(ii) At any time within thirty (30) days after receipt by the Offeree Investor of the Offer
Notice (the “Option Period”), the Offeree Investor (or any of its Affiliates) may elect to
accept the offer to purchase with respect to all but not less than all of the Offered Shares and
shall give written notice of such election (the “Acceptance Notice”) to the Transferring
Investor within the Option Period. The Acceptance Notice shall constitute a valid, legally binding
and enforceable agreement for the sale and purchase of the Offered Shares.

(iii) In the event that the Offeree Investor does not elect (together with its Affiliates) to
purchase all of the Offered Shares pursuant to Section 3.2(b)(ii), during the one hundred
twenty (120)-day period following the expiration of the Option Period the Transferring Investor may
sell all or any portion of the Offered Shares to one or more Third Parties at a price not less than
ninety-five percent (95%) of the price specified in the Offer Notice and otherwise on the terms and
conditions set forth in the Offer Notice; provided, that, if following such Transfer (and
any related or contemporaneous acquisition of Beneficial Ownership by such Third Party of any
shares of Common Stock, Other Capital Stock or Convertible Notes), any such Third Party will
Beneficially Own five percent (5%) or more of the Outstanding Stock, such Third Party shall (A) be
reasonably acceptable to the Offeree Investor and (B) comply with Section 3.2(c) below. If
the Transferring Investor does not consummate the Transfer of any of the Offered Shares in
accordance with this Section 3.2(b)(iii) within such one hundred twenty (120)-day period,
then the Transferring Investor may not Transfer such Offered Shares unless it sends a new Offer
Notice and once again complies with the provisions of this Section 3.2(b) with respect to
such Offered Shares.

(c) No Investor shall Transfer any Investor Shares to any Third Party unless (i) upon
consummation of such Transfer and any related or contemporaneous acquisition of Beneficial
Ownership by such Third Party of any shares of Common Stock, Other Capital Stock or Convertible
Notes, such Third Party Beneficially Owns less than five percent (5%) of the Outstanding Stock or
(ii) as a condition to the consummation of such Transfer, such Third Party executes and delivers to
the Company and each Investor (other than the Investor effecting such Transfer) an agreement
assuming the obligations of an Investor set forth in this Agreement in form and substance
reasonably satisfactory to the Company and each such Investor; provided, that, it is agreed
and acknowledged that the rights of each Investor set forth in Section 3.1 of this
Agreement are personal to such Investor and no Investor shall Transfer, delegate or assign, whether
in connection with any sale of any Investor Shares or otherwise, any right of such Investor under
Section 3.1 of this Agreement to another Investor or to any Third Party. Except as set
forth in the preceding sentence, all other rights of each Investor set forth in this Agreement may
be Transferred to the Third Party to which the Investor Shares are being Transferred.

(d) Notwithstanding anything herein to the contrary the restrictions on transfer in this
Section 3.2 shall not apply to any Transfer by an Investor to its Affiliates;
provided, that such Affiliate executes and delivers to the Company and each Investor (other
than the Investor effecting such Transfer) an agreement assuming the obligations of an Investor set
forth in this Agreement in form and substance reasonably satisfactory to the Company and each such
Investor.

(e) Any purported Transfer, delegation or assignment not in conformity with this Section
3.2 shall be null and void ab initio.

Section 3.3 Majority Voting Provision. Except as otherwise agreed to in writing by
the Requisite Investors or as required by Law, the Company shall (and each Investor shall take, or
cause to be taken, all other Necessary Action, to) ensure that each directorship shall be elected
by a plurality of the votes cast.

Section 3.4 Controlled Company Exemption.

(a) Each Investor shall take all Necessary Action for the Company to be treated as a
“controlled company” as defined by Rule 5615(c) of the NASDAQ Marketplace Rules and make all
necessary filings and disclosures associated with such status; provided, that nothing in
this Section 3.4 shall be deemed to prohibit any Transfer of Shares effected in compliance
with Section 3.2. If, at any time, the Company ceases to qualify as a “controlled company”
under NASDAQ Marketplace Rules, the Investors shall take, or cause to be taken, all Necessary
Action to cause a sufficient number of their designees (including Directors designated pursuant to
Section 3.1(b)(iv)) to qualify as Independent Directors to ensure that the Board complies
with applicable NASDAQ Marketplace Rules regarding the independence of the Board within the time
periods specified under Rule 5615(c)(3) of the NASDAQ Marketplace Rules.

(b) For so long as the Company qualifies as a “controlled company” as defined by Rule 5615(c)
of the NASDAQ Marketplace Rules, the Company will elect to be a “controlled company” for purposes
of such applicable listing standards, and will disclose in its annual meeting proxy statement that
it is a “controlled company” and the basis for that determination.

Section 3.5 Covenants.

(a) The Company shall not, and shall not permit any Subsidiary of the Company to, without
first having provided written notice of such proposed action to each Investor and having obtained
the approval of a majority of the Independent Directors (whether at a meeting of the Board or any
committee thereof, or in writing), enter into or commit to enter into any Contract, arrangement or
understanding between (x) the Company and its direct or indirect Subsidiaries, on the one hand, and
(y) any Investor, any Affiliate of an Investor or any related person within the meaning of Item 404
of Regulation S-K promulgated under the Exchange Act, on the other hand, in each case, other than
(i) transactions that do not constitute a transaction with a related person within the meaning of
Item 404 of Regulation S-K promulgated under the Exchange Act (treating each Investor and each of
its Affiliates as a related person for such purposes) and (ii) this Agreement, the Registration
Rights Agreement, the Convertible Notes and the Management Agreements, and the transactions
contemplated by each of the foregoing Contracts (each as in effect on the date hereof, without
giving effect to any amendment or modification thereto, or waiver thereunder, unless such
amendment, modification or waiver was approved by a majority of the Independent Directors then
serving on the Board pursuant to this Section 3.5(a));

(b) During the period beginning on the date of this Agreement and ending on the earlier of (X)
April 13, 2014 and (Y) the date on which the Investors, collectively, Beneficially Own Investor
Shares representing less than thirty-five percent (35%) of the Outstanding Stock, the Company shall
not, and shall not permit any Subsidiary of the Company to, without first having provided written
notice of such proposed action to each Investor and having obtained the prior written consent of
the Requisite Investors:

(i) (A) acquire or dispose of any corporation, entity, division or other business concern
having a value in excess of $10,000,000 in a single transaction or series of related transactions,
whether by acquisition or disposition of assets or capital stock, merger, consolidation or
otherwise, and whether in consideration of the payment of cash, the issuance of capital stock or
otherwise or (B) dissolve, liquidate or engage in any recapitalization or reorganization of the
Company or any of its material Subsidiaries or the filing for bankruptcy by the Company or any of
its Subsidiaries;

(ii) replace Peter Gleysteen, or any successor thereto, as the Chief Executive Officer of the
Company or maintain the Company’s headquarters outside of New York, New York;

(iii) issue any New Shares or issue any Equity Interests in a registration under the
Securities Act, whether or not in an underwritten public offering, other than (X) registrations
pursuant to the Registration Rights Agreement or (Y) the issuance of Equity Interests as
consideration in the acquisition of any Person, whether by acquisition of assets or capital stock,
merger, consolidation or otherwise, representing immediately following the issuance thereof less
than five percent (5%) of the Outstanding Stock; or

(iv) incur, assume or guarantee any indebtedness for borrowed money (including pursuant to
debt securities issued in registered public offering), except for (A) indebtedness incurred in the
ordinary course of business not in excess of $20,000,000 in the aggregate and (B) repurchase
obligations pursuant to the Company’s investments in residential mortgage-backed securities,
provided, that such repurchase obligations do not exceed $275,000,000 or such other amount
as is established by the Board from time to time.

(c) CMA Requirements:

(i) CIFC Parent hereby represents and warrants that, on the date hereof, CIFC Parent holds,
directly or indirectly, beneficial ownership (within the meaning of the applicable CMA Requirement)
of a sufficient number of Equity Interests or other securities of each CIFC CLO Issuer necessary to
satisfy the minimum ownership requirements for CIFC and its Affiliates under the CMA Requirement
relating to such CIFC CLO Issuer.

(ii) Unless the Company elects, in its sole discretion, to obtain the prior written consent of
the applicable CIFC CLO Issuer and such consent is actually obtained, CIFC Parent covenants that:

(A) CIFC Parent shall not Transfer any Equity Interest or other security of such CIFC
CLO Issuer to any Person other than the Company or one of its Subsidiaries unless, following
such Transfer, CIFC Parent continues to hold, directly or indirectly, beneficial ownership
(within the meaning of the applicable CMA Requirement) of a sufficient number of Equity
Interests or other securities of such CIFC CLO Issuer necessary to satisfy the minimum
ownership requirements for CIFC and its Affiliates under the CMA Requirement relating to
such CIFC CLO Issuer;

(B) CIFC Parent shall use commercially reasonable efforts and take all other Necessary
Action to remain, and not take any action that would cause it to no longer be, an
“affiliate” of CIFC (as such term is used in the applicable CIFC CLO Management Agreement
and CMA Requirement);

(C) CIFC Parent shall have, appoint, elect and cause to be appointed and elected, and
take all other Necessary Action to action and elect, the Chief Executive Officer of the
Company shall be the Chief Executive Officer of CIFC Parent; and

(D) (1) each Director designated by CIFC Parent pursuant to Section 3.1(b)(ii)
shall also be a member of the board of directors or equivalent governing body of CIFC Parent
and (2) the Chief Executive Officer and the board of directors or equivalent governing body
of CIFC Parent shall, collectively, have the power to manage the business and affairs of
CIFC Parent.

(iii) Notwithstanding anything to the contrary in Section 5.1, the covenants set forth
in this Section 3.5(c) shall only terminate as to a CIFC CLO Issuer and the related CIFC
CLO Management Agreement upon the earliest of (w) the Transfer of Equity Interests or other
securities of such CIFC CLO Issuer to the Company or one of its Subsidiaries necessary to satisfy
the CMA Requirement of the applicable CIFC CLO Issuer, (x) such time as CIFC ceases to be the
“Collateral Manager” under such CIFC CLO Management Agreement, other than as a result of a breach
of this Section 3.5(c), (y) the termination of such CIFC CLO Management Agreement, other
than as a result of a breach of this Section 3.5(c) and (z) the amendment of such CIFC CLO
Management Agreement to remove the applicable CMA Requirement.

(iv) In the event that the Company or any of its Subsidiaries, in the Company’s sole
discretion, seeks the consent of the same Persons as are required to amend the applicable CMA
Requirement to any amendment of any CIFC CLO Management Agreement, the Company shall use reasonable
good faith efforts to obtain the consent of such Persons to remove the applicable CMA Requirement
of such CIFC CLO Management Agreement.

(v) The calculation of any loss or damages incurred by the Company upon, attributable to or
resulting from any breach by CIFC Parent of its obligations under this Section 3.5(c) or
any event, occurrence or circumstance resulting in the statement in Section 3.5(c)(ii)(D)
ceasing to be true and correct in any respect shall include the loss of management fees resulting
from the removal of the Company and its Subsidiaries as the manager under each CIFC CLO Management
Agreement. CIFC Parent hereby agrees and acknowledges that it shall be deemed a breach of CIFC
Parent’s covenant set forth in Section 3.5(c)(ii)(D) if the statements set forth therein
cease to be true and correct in any respect.

(vi) Notwithstanding anything to the contrary in Section 5.1 and Section 5.12,
the provisions of this Section 3.5(c) may not be terminated, amended or modified unless
such termination, amendment or modification is approved by not less than a majority of the
Independent Directors then serving on the Board and DFR Holdings, for so long as it remains party
to this Agreement.

Section 3.6 Committee Membership.

(a) The Board shall establish and maintain:

(i) a compensation committee, which shall include at least one (1) Independent Director;

(ii) a Nominating Committee which shall be comprised of three (3) Directors, including (A) one
(1) Director designated by DFR Holdings so long as DFR Holdings has the right to designate at least
two (2) Directors to the Board pursuant to Section 3.1, (B) one (1) director designated by
CIFC Parent so long as CIFC Parent has the right to designate at least two (2) Directors to the
Board pursuant to Section 3.1, and (C) the remainder of the Directors shall be Independent
Directors designated to the Nominating Committee by approval of a majority of the Board; and

(iii) to the extent required by applicable Law, an audit committee, which shall have at least
three (3) members and be comprised entirely of Independent Directors who meet the independence
requirements for audit committee members promulgated by NASDAQ and the SEC (including Rule
5605(c)(2) of the NASDAQ Marketplace Rules and Rule 10A-3(b)(1) under the Exchange Act). The
Nominating Committee shall take, or cause to be taken, all Necessary Action to cause a sufficient
number of the Independent Directors designated pursuant to Section 3.1(b)(iv) to meet the
independence requirements for audit committee members promulgated by NASDAQ and the SEC (including
Rule 5605(c)(2) of the NASDAQ Marketplace Rules and Rule 10A-3(b)(1) under the Exchange Act).

(b) The Board shall not establish or maintain any other committees without the prior written
consent of the Requisite Investors. Without limitation of the foregoing, the strategic committee
of the Board shall be dissolved on or prior to the date hereof and shall not be re-formed without
the prior written consent of the Requisite Investors.

Section 3.7 Board Observers. In addition to the rights of the Investors in
Section 3.1, each Investor (for so long as the Investor Shares held by such Investor
represent at least fifteen percent (15%) of the Outstanding Stock) shall be entitled to designate
one observer to attend (but not vote) at all meetings of the Board and each committee of the Board;
provided, that notwithstanding anything herein to the contrary, the Board or such committee
may exclude any such observer from access to any materials or meeting or portion thereof if (a) the
Board or such committee (as applicable) determines in good faith to so exclude such observer,
including if the Board or such committee (as applicable) determines in good faith that upon advice
of counsel, such exclusion is reasonably necessary to preserve the attorney-client privilege or (b)
such observer has not entered into a confidentiality agreement in form and substance reasonably
satisfactory to the Company.

Section 3.8 Preemptive Rights.

(a) Subject to Section 3.9, for so long as any Investor Beneficially Owns Investor
Shares representing at least five percent (5%) of the Denominator Shares, such Investor shall have,
the right to purchase, in accordance with the procedures set forth herein, its pro rata portion,
calculated based on the number of Investor Shares held by such Investor as a percentage of the
Denominator Shares prior to issuance of the New Shares (such Investor’s “Pro Rata Portion”)
of any New Shares that the Company may, from time to time, propose to sell and issue (hereinafter
referred to as the “Preemptive Right”).

(b) In the event that the Company proposes to issue and sell New Shares, the Company shall
notify each of the Investors in writing with respect to the proposed New Shares to be issued (the
“New Shares Notice”). Each New Shares Notice shall set forth: (i) the number of New Shares
proposed to be issued by the Company and the purchase price therefor; (ii) each Investor’s Pro Rata
Portion of such New Shares; and (iii) any other material term (including, if known, the expected
date of consummation of the purchase and sale of the New Shares).

(c) Each Investor (together with its Affiliates) shall be entitled to exercise its right to
purchase New Shares by delivering an irrevocable written notice to the Company within fifteen (15)
days from the date of receipt of any such New Shares Notice specifying the number of New Shares to
be subscribed, which in any event can be no greater than such Investor’s Pro Rata Portion of such
New Shares at the price and on the terms and conditions specified in the New Shares Notice.

(d) If the Investors (together with their Affiliates) do not elect within the applicable
notice period described above to exercise their Preemptive Rights with respect to any of the New
Shares proposed to be sold by the Company, the Company shall have ninety (90) days after expiration
of such notice period to sell such unsubscribed New Shares proposed to be sold by the Company, at a
price and on terms no more favorable to the purchaser than those set forth in the New Shares
Notice. If the Company does not consummate the sale of the unsubscribed New Shares in accordance
with the terms of the New Shares Notice within such ninety (90)-day period, then the Company may
not issue or sell such New Shares unless it sends a new New Shares Notice and once again complies
with the provisions of this Section 3.8 with respect to such New Shares.

(e) Each Investor (together with its Affiliates) shall take up and pay for any New Shares that
such Investor (together with its Affiliates) has elected to purchase pursuant to the Preemptive
Right upon closing of the issuance of the New Shares, and shall have no right to acquire such New
Shares if the issuance thereof shall not be consummated.

Section 3.9 Standstill.

(a) Except as set forth in this Section 3.9(a), no Investor shall acquire Beneficial
Ownership of shares of Common Stock or Other Capital Stock, or any security which is convertible
into Common Stock or Other Capital Stock, except:

(i) if (A) such acquisition is pursuant to a tender offer or exchange offer for outstanding
shares of Common Stock, or a merger pursuant to a merger agreement with the Company, made by the
Investor or of any Affiliate thereof (the “Bidder”) and in each case is either (1) approved
by not less than a majority of the Independent Directors or (2) initiated by an Investor in
response to a tender offer or exchange offer by a Third Party (such tender offer or exchange offer,
an “Approved Offer,” and such merger, an “Approved Merger”), and (B) in such
Approved Offer, not less than a majority of the Subject Shares (as defined below) are tendered into
such Approved Offer and not withdrawn prior to the final expiration of such Approved Offer, or in
such Approved Merger, not less than a majority of the Subject Shares that are affirmatively voted
(in person or by proxy) on the related merger proposal (and not withdrawn) are voted for (i.e., in
favor) of such proposal;

(ii) acquisitions of Conversion Shares upon conversion of the Convertible Notes;

(iii) acquisitions of Common Stock issued (including pursuant to exercise of stock options
granted) to any Director designated by such Investor in respect of such Director’s service on the
Board;

(iv) acquisitions of Common Stock pursuant to any stock split, stock dividend or the like
effected by the Company;

(v) acquisitions that would not result in (A) such Investor Beneficially Owning a percentage
of the then Outstanding Stock that is greater than such Investor’s Cap Percentage or (B) all
Investors Beneficially Owning a percentage of the then Outstanding Stock that is greater than the
Aggregate Cap Percentage;

(vi) acquisitions pursuant to such Investor’s right of first refusal under Section
3.2(a) or right of first offer under Section 3.2(b); and

(vii) acquisitions approved by a majority of the Independent Directors then serving on the
Board (including pursuant to any merger, acquisition or other transaction that is approved by a
majority of the Independent Directors then serving on the Board).

As used in this Section 3.9(a), “Subject Shares” means the then outstanding shares
of Common Stock and Other Capital Stock not owned by the Bidder.

(b) All of the restrictions set forth in this Section 3.9 shall terminate in respect
of an Investor upon the earlier to occur of:

(i) the entry by the Company into a definitive agreement with any Person (including the other
Investor in accordance with the terms of this Agreement) providing for: (x) a recapitalization,
merger, share exchange, business combination or similar extraordinary transaction as a result of
which the Persons that Beneficially Own the voting securities of the Company (immediately prior to
the consummation of such transaction) would cease to (immediately after consummation of such
transaction) Beneficially Own voting securities entitling them to vote a majority or more of the
Outstanding Stock in the elections of directors of the Company at any annual or special meeting
(or, if the Company is not the surviving or resulting entity, the equivalent governing body of such
surviving or resulting entity); (y) a sale of all or substantially all of the assets the Company
(determined on a consolidated basis), in one transaction or series of related transactions; or (z)
the acquisition (by purchase, merger or otherwise) by any Person (including any syndicate or group
deemed to be a “person” under Section 13(d)(3) of the Exchange Act) of Beneficial Ownership of
voting securities of the Company entitling that Person to vote a majority of the Outstanding Stock
(the transactions described in clauses (x), (y) and (z) of this subsection being each hereinafter
referred to as a “Transaction Agreement”); and

(ii) such date as the Investor Shares Beneficially Owned by such Investor represent less than
five percent (5%) of the Outstanding Stock (after giving effect to any Cure Purchase hereunder).

(c) Each Investor agrees that such Investor shall, as a condition precedent to any Transfer by
such Investor to a Third Party of Investor Shares representing fifteen percent (15%) or more of the
Outstanding Stock, require that such Third Party enter into a written agreement with the Company
providing that such Third Party will agree to be bound by the terms of this Section 3.9.
Any purported sale or transfer by the Investor without compliance of the obligation in the
preceding sentence shall be null and void ab initio. For the avoidance of doubt, the requirements
of this Section 3.9(c) shall apply to any Person acquiring Investor Shares representing
fifteen percent (15%) or more of the Outstanding Stock even if following such Transfer such selling
Investor would own Investor Shares representing less than five percent (5%) of the Outstanding
Stock.

(d) Notwithstanding anything to the contrary in Section 5.1 and Section 5.12,
the provisions of this Section 3.9 may not be terminated, amended or modified unless such
termination, amendment or modification is approved by a majority of the Independent Directors then
serving on the Board.

Article IV

NON SOLICITATION

Section 4.1 Non Solicitation.

(a) Without the consent of the Board, for so long as any Investor holds Investor Shares
representing at least five percent (5%) of the Outstanding Stock and for twelve (12) months
thereafter (the “Tail Period”), such Investor and its Affiliates shall not, directly or
indirectly:

(i) solicit for employment or any similar arrangement or hire any employee of the Company or
any of its Affiliates; provided, however, that this Section 4.1 shall not
prohibit the hiring of a person (A) whose employment has been terminated by the Company without any
solicitation or encouragement by such Investor or any of its Affiliates more than six (6) months
prior to the date of the solicitation or hiring of such person by such Investor or any of its
Affiliates or (B) who responds to general solicitations of employment through advertisements or
other means not targeted specifically to such employees; or

(ii) solicit, or attempt to solicit or induce, on behalf of any Person other than the Company
or any of its Subsidiaries, any person or entity that is (or was during the one (1) year period
prior to any solicitation by such Investor or its Affiliates) a Company Investor or Company Client
or an investment advisor or collateral manager to any Company Investor or Company Client to (A)
terminate, reduce or otherwise adversely modify its relationship with the Company or any of its
Subsidiaries, or (B) to otherwise use the investment management services provided by a Person other
than the Company or any of its Subsidiaries.

(b) After the Merger Agreement Closing and so long as an Investor or any of its Affiliates
owns (other than in a fiduciary capacity or subject to a similar duty or standard of care) any
Equity Interests or debt securities issued by any, as applicable, Company CDO Issuer, CIFC CLO
Issuer or CypressTree CLO Issuer and the Company or its Affiliates (or its successor if such
successor is Affiliated with the Company) is the manager under the applicable Company CDO
Management Agreement, CIFC CLO Management Agreement or CypressTree CLO Management Agreement,
respectively, such Investor agrees (and agrees to cause its Affiliates) (i) not to vote such Equity
Interests or debt securities in favor of the redemption of any securities issued by such Company
CDO Issuer, CIFC CLO Issuer or CypressTree CLO Issuer under any indenture among the Company CDO
Issuer Documents, CIFC CDO Issuer Documents or CypressTree CLO Issuer Documents, respectively, and
(ii) not to vote in favor of removal of the Company or any of its Affiliates as the manager under
such Company CDO Management Agreement, CIFC CLO Management Agreement or CypressTree CLO Management
Agreement.

Article V

MISCELLANEOUS

Section 5.1 Termination of Agreement.

(a) This Agreement shall continue in effect until:

(i) Terminated by written agreement of the Company and the Requisite Investors; or

(ii) Terminated by the Company with fifteen (15) days’ prior written notice to the applicable
Investor (the “Termination Notice”) upon such time as the Investor Shares Beneficially
Owned by such Investor represent less than five percent (5%) of the Outstanding Stock;
provided, however, that this Section 5.1(a)(ii) shall apply only if, prior
to delivery by the Company of the Termination Notice to such Investor, the Company has delivered to
such Investor a Dilution Notice in accordance with Section 3.1(d)(iii) hereof (mutatis
mutandis) and such Investor has not, within the respective time periods specified in Section
3.1(d)(iii) (mutatis mutandis), given the Company written notice of their intention to effect a
Cure Purchase and consummated such Cure Purchase.

(b) The obligations of each Investor pursuant to Section 4.1 shall survive the
termination of this Agreement as to such Investor until the expiration of the Tail Period. The
obligations of CIFC Parent pursuant to Section 3.5(c) shall survive the termination of this
Agreement as to CIFC Parent until the expiration of such obligations in accordance with Section
3.5(c)(iii).

Section 5.2 Expenses. Except as otherwise expressly set forth herein, each party
hereto shall pay its own costs and expenses (including all legal, accounting, broker, finder and
investment banker fees) relating to this Agreement, the negotiations leading up to this Agreement
and the transactions contemplated hereby.

Section 5.3 Notices. All notices, demands and other communications pertaining to this
Agreement (“Notices”) shall be in writing and addressed as follows:

If to the Company:

CIFC Corp.

250 Park Avenue, 4th Floor

New York, NY 10177

Attention: Robert C. Milton III

Email: rmilton@cifc.com

 

with copies to:

Goodwin Procter LLP

53 State Street

Boston, MA 02109

Attention: John Mutkoski, Esq.; Amber Dolman, Esq.

E-mail: jmutkoski@goodwinprocter.com; adolman@goodwinprocter.com

 

If to DFR Holdings, LLC:

DFR Holdings, LLC

c/o Columbus Nova

900 Third Avenue, 19th Floor

New York, NY 10022

Attention: Paul Lipari

Email: plipari@columbusnova.com

 

with copies to:

Latham & Watkins LLP

885 Third Avenue

New York, NY 10022

Attention: James C. Gorton, Esq.

E-mail Address: james.gorton@lw.com

 

If to CIFC Parent Holdings LLC:

CIFC Parent Holdings LLC

c/o Charlesbank Capital Partners, LLC

200 Clarendon Street, 54th Floor

Boston, MA 02116

Attention: Tim R. Palmer

E-mail: tpalmer@charlesbank.com

 

with copies to:

Goodwin Procter LLP

135 Commonwealth Drive

Menlo Park, CA 94025

Attention: Kevin M. Dennis, Esq.

E-mail: kdennis@goodwinprocter.com

 

Notices shall be deemed given (a) on the first (1st) business day after being sent,
prepaid, by nationally recognized overnight courier that issues a receipt or other confirmation of
delivery, (b) upon machine generated acknowledgement of receipt after transmittal by facsimile if
so acknowledged to have been received before 5:00 p.m. on a business day at the location of receipt
and otherwise on the next following business day or (c) when sent, if sent by electronic mail
before 5:00 p.m. on a business day at the location of receipt and otherwise the next following
business day. Any party may change the address to which Notices under this Agreement are to be
sent to it by giving written notice of a change of address in the manner provided in this Agreement
for giving Notice.

Section 5.4 Governing Law. EXCEPT TO THE EXTENT THAT THE LAWS OF THE STATE OF
DELAWARE APPLICABLE TO THE ELECTION OR REMOVAL OF DIRECTORS ARE APPLICABLE, THIS AGREEMENT WILL BE
GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF NEW
YORK WITHOUT REFERENCE TO ITS CHOICE OF LAW RULES THAT WOULD APPLY THE LAWS OF ANY OTHER
JURISDICTION.

Section 5.5 Consent to Jurisdiction. Each party to this Agreement, by its execution
hereof, (a) hereby irrevocably consents and agrees that any action, suit or proceeding arising in
connection with any disagreement, dispute, controversy or claim, in whole or in part, arising out
of, related to, based upon or in connection with this Agreement or the subject matter hereof shall
be brought only in the courts of the State Courts of the State of New York, New York County or the
United States District Court located in the State of New York, New York County, (b) hereby waives
to the extent not prohibited by applicable Law, and agrees not to assert, by way of motion, as a
defense or otherwise, in any such action, any claim that it is not subject personally to the
jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that any such action brought in one of the above-named courts should be dismissed on
grounds of forum non conveniens, should be transferred to any court other than one of the
above-named courts, or should be stayed by reason of the pendency of some other proceeding in any
other court other than one of the above-named courts, or that this Agreement or the subject matter
hereof may not be enforced in or by such court and (c) hereby agrees not to commence any such
action other than before one of the above-named courts nor to make any motion or take any other
action seeking or intending to cause the transfer or removal of any such action to any court other
than one of the above-named courts whether on the grounds of forum non conveniens or otherwise.
Each party hereby (i) consents to service of process in any such action in any manner permitted by
New York law, (ii) agrees that service of process made in accordance with clause (i) or made by
registered or certified mail, return receipt requested, at its address specified pursuant to
Section 5.3, shall constitute good and valid service of process in any such action, and
(iii) waives and agrees not to assert (by way of motion, as a defense, or otherwise) in any such
action any claim that service of process made in accordance with clause (i) or (ii) does not
constitute good and valid service of process.

Section 5.6 Specific Performance. The parties to this Agreement each acknowledge that
each party would not have an adequate remedy at law for money damages in the event that any of the
covenants hereunder have not been performed in accordance with their terms, and therefore agree
that each other party hereto shall be entitled to specific enforcement of the terms hereof and any
other equitable remedy to which such Party may be entitled. Each of the Parties hereby waives (i)
any defenses in any action for specific performance, including the defense that a remedy at law
would be adequate and (ii) any requirement under any Law to post a bond or other security as a
prerequisite to obtaining equitable relief.

Section 5.7 Waiver of Jury Trial. The parties each hereby waive trial by jury in any
judicial proceeding involving, directly or indirectly, any matters (whether sounding in tort,
contract or otherwise) in any way arising out of, related to or connected with this Agreement or
the transactions contemplated hereby.

Section 5.8 Binding Effect; Persons Benefiting; Assignment. This Agreement shall
inure to the benefit of and be binding upon the parties hereto and their respective successors and
permitted assigns. Nothing in this Agreement is intended or shall be construed to confer upon any
Person other than the parties hereto and their respective successors and permitted assigns any
right, remedy or claim under or by reason of this Agreement or any part hereof. Without the prior
written consent of the other party hereto, this Agreement may not be assigned by either party
hereto and any purported assignment made without such consent shall be null and void.

Section 5.9 Counterparts. This Agreement may be executed in counterparts (including
by facsimile or other electronic transmission), each of which shall be deemed an original and each
of which shall constitute one and the same instrument.

Section 5.10 Entire Agreement. This Agreement, including the Schedules, Exhibits,
Annexes, certificates and lists referred to herein, any documents executed by the Parties
simultaneously herewith or pursuant thereto constitute the entire understanding and agreement of
the Parties hereto with respect to the subject matter hereof and supersedes all other prior
agreements and understandings, written or oral, between the Parties with respect to such subject
matter (including without limitation, the Original Agreement). Each of the Company and DFR
Holdings hereby agrees, approves and consents, by its signature hereto, that the Original Agreement
be, and hereby is, amended and restated in its entirety to read as set forth herein.

Section 5.11 Severability. If any provision of this Agreement, or the application
thereof to any Person or circumstance, is invalid or unenforceable in any jurisdiction, (a) a
substitute and equitable provision shall be substituted therefor in order to carry out, so far as
may be valid and enforceable in such jurisdiction, the intent and purpose of their invalid or
unenforceable provision; and (b) the remainder of this Agreement and the application of such
provision to other Persons or circumstances shall not be affected by such invalidity or
unenforceability, nor shall such invalidity or unenforceability of such provision affect the
validity or enforceability of such provision, or the application thereof, in any other
jurisdiction.

Section 5.12 Amendments and Waivers. This Agreement may not be amended, altered or
modified except by written instrument executed by each Investor and the Company and approved by a
majority of the Independent Directors then serving on the Board (whether at a meeting of the Board
or any committee thereof, or in writing); provided, however, that this Agreement
may be amended without the consent of an Investor if the Investor Shares Beneficially Owned by such
Investor represent less than five percent (5%) of the Outstanding Stock (after giving effect to any
Cure Purchase hereunder), except that Section 3.5(c) and Section 4.1 may not be so
amended in a manner that adversely affects such Investor without such Investor’s consent. The
failure by any party hereto to enforce at any time any of the provisions of this Agreement shall in
no way be construed to be a waiver of any such provision nor in any way to affect the validity of
this Agreement or any part hereof or the right of such party thereafter to enforce each and every
such provision. No waiver of any breach of or non-compliance with this Agreement shall be held to
be a waiver of any other or subsequent breach or non-compliance. Any waiver made by any party
hereto in connection with this Agreement shall not be valid unless agreed to in writing by such
party.

Section 5.13 Delays or Omissions. No delay or omission to exercise any right, power,
or remedy accruing to any party under this Agreement shall impair any such right, power, or remedy
of such party, nor shall it be construed to be a waiver of or acquiescence to any breach or
default, or of or in any similar breach or default thereafter occurring; nor shall any waiver of
any single breach or default be deemed a waiver of any other breach or default. All remedies,
either under this Agreement or by law or otherwise afforded to any holder, shall be cumulative and
not alternative.

Section 5.14 Mutual Drafting; Interpretation. Each party hereto has participated in
the drafting of this Agreement, which each such party acknowledges is the result of extensive
negotiations between the parties. If an ambiguity or question of intent or interpretation arises,
this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provision.

[Remainder of Page Left Blank]

4

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above
written.

	 	 	 
	 	 	COMPANY:

	 	 	CIFC CORP.

	 
	 	By:  /s/ Peter Gleysteen

	 	 	 

	 	 	Name: Peter Gleysteen

Title: Chief Executive Officer

	 	 	 

	 	 	DFR HOLDINGS:

	      
	 	DFR HOLDINGS, LLC

	 	 	By:  /s/ Andrew Intrater

	 	 	 

	 	 	Name:Andrew Intrater

Title: Manager

	        
	 	 

	 	 	CIFC PARENT:

	 	 	CIFC PARENT HOLDINGS LLC

	 	 	By:  /s/ Michael Eisenson

	 	 	 

	 	 	Name:Michael Eisenson

Title: Director

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]